Table of Contents

Namespaces

This section lists all of the namespaces that are defined in the original BEL script.

AFFX
http://resources.openbel.org/belframework/20150611/namespace/affy-probeset-ids.belns
CHEBI
http://resources.openbel.org/belframework/20150611/namespace/chebi.belns
CHEBIID
http://resources.openbel.org/belframework/20150611/namespace/chebi-ids.belns
CHEMBL
http://belief.scai.fraunhofer.de/openbel/repository/namespaces/chembl-names.belns
CHEMBLID
http://belief.scai.fraunhofer.de/openbel/repository/namespaces/chembl-ids.belns
DO
http://resources.openbel.org/belframework/20150611/namespace/disease-ontology.belns
DOID
http://resources.openbel.org/belframework/20150611/namespace/disease-ontology-ids.belns
EGID
http://resources.openbel.org/belframework/20150611/namespace/entrez-gene-ids.belns
GOBP
http://resources.openbel.org/belframework/20150611/namespace/go-biological-process.belns
GOBPID
http://resources.openbel.org/belframework/20150611/namespace/go-biological-process-ids.belns
GOCC
http://resources.openbel.org/belframework/20150611/namespace/go-cellular-component.belns
GOCCID
http://resources.openbel.org/belframework/20150611/namespace/go-cellular-component-ids.belns
HGNC
http://resources.openbel.org/belframework/20150611/namespace/hgnc-human-genes.belns
LMSD
http://belief.scai.fraunhofer.de/openbel/repository/namespaces/LMSD.belns
MESHC
http://resources.openbel.org/belframework/20150611/namespace/mesh-chemicals.belns
MESHCID
http://resources.openbel.org/belframework/20150611/namespace/mesh-chemicals-ids.belns
MESHCS
http://resources.openbel.org/belframework/20150611/namespace/mesh-cellular-structures.belns
MESHCSID
http://resources.openbel.org/belframework/20150611/namespace/mesh-cellular-structures-ids.belns
MESHD
http://resources.openbel.org/belframework/20150611/namespace/mesh-diseases.belns
MESHDID
http://resources.openbel.org/belframework/20150611/namespace/mesh-diseases-ids.belns
MESHPP
http://resources.openbel.org/belframework/20150611/namespace/mesh-processes.belns
MESHPPID
http://resources.openbel.org/belframework/20150611/namespace/mesh-processes-ids.belns
MGI
http://resources.openbel.org/belframework/20150611/namespace/mgi-mouse-genes.belns
PH
http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Placeholder.belns
PMIBP
http://belief.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmibp.belns
PMICHEM
http://belief.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmichem.belns
PMICOMP
http://belief.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmicomp.belns
PMIDIS
http://belief.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmidis.belns
PMIPFAM
http://belief.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmipfam.belns
RGD
http://resources.openbel.org/belframework/20150611/namespace/rgd-rat-genes.belns
SCHEM
http://resources.openbel.org/belframework/20150611/namespace/selventa-legacy-chemicals.belns
SCOMP
http://resources.openbel.org/belframework/20150611/namespace/selventa-named-complexes.belns
SDIS
http://resources.openbel.org/belframework/20150611/namespace/selventa-legacy-diseases.belns
SFAM
http://resources.openbel.org/belframework/20150611/namespace/selventa-protein-families.belns
SP
http://resources.openbel.org/belframework/20150611/namespace/swissprot.belns
SPID
http://resources.openbel.org/belframework/20150611/namespace/swissprot-ids.belns
ZFIN
http://belief.scai.fraunhofer.de/openbel/repository/namespaces/zfin-zebrafish-genes.belns

Unused Namespaces 20

The source BEL script contained references to the following namespaces, but they were never used. It is suggested to delete their definitions from the BEL script to improve readability and parsing speed.

  • AFFX
  • CHEBIID
  • CHEMBL
  • DOID
  • GOBPID
  • GOCCID
  • LMSD
  • MESHCID
  • MESHCS
  • MESHCSID
  • MESHDID
  • MESHPPID
  • PMIBP
  • PMICHEM
  • PMICOMP
  • PMIDIS
  • PMIPFAM
  • SP
  • SPID
  • ZFIN

Annotations

This section lists all of the annotations that are defined in the original BEL script.

Keyword URL Stratify
Anatomy http://resources.openbel.org/belframework/20150611/annotation/anatomy.belanno View Stratified Summary
Cell http://resources.openbel.org/belframework/20150611/annotation/cell.belanno View Stratified Summary
CellLine http://resources.openbel.org/belframework/20150611/annotation/cell-line.belanno View Stratified Summary
CellStructure http://resources.openbel.org/belframework/20150611/annotation/cell-structure.belanno View Stratified Summary
Disease http://resources.openbel.org/belframework/20150611/annotation/disease.belanno View Stratified Summary
Eco http://belief.scai.fraunhofer.de/openbel/repository/annotation/evidence.belanno View Stratified Summary
MeSHAnatomy http://resources.openbel.org/belframework/20150611/annotation/mesh-anatomy.belanno View Stratified Summary
MeSHDisease http://resources.openbel.org/belframework/20150611/annotation/mesh-diseases.belanno View Stratified Summary
Species http://belief.scai.fraunhofer.de/openbel/repository/annotation/ncbi-taxonomy-id.belanno View Stratified Summary
SpeciesNames http://belief.scai.fraunhofer.de/openbel/repository/annotation/ncbi-taxonomy-names.belanno View Stratified Summary

Unused Annotations 16

The source BEL script contained references to the following annotations, but they were never used. It is suggested to delete their definitions from the BEL script to improve readability and parsing speed.

Note: this may be due to errors occurring in all statements with these annotations.

  • BRCO
  • Cell
  • Condition
  • Developmental_Phase__of_patient
  • DiseaseState
  • Duration_of_Chemical_Exposure
  • Encode_Feature_Types
  • Experimental_Group
  • FDASTATUS
  • KnockoutMice
  • NIFT
  • Patient
  • Race
  • Transcriptionally_active_region
  • UserdefinedCell
  • UserdefinedCellLine

Locally Defined Annotations 23

The source BEL script contained annotations defined as a list. Click each link to export the list definition as a BELANNO file that can hosted externally to promote re-usability and interoperability. After, you can replace the list definition in the source BEL with a SET ANNOTATION X AS URL "Y" definition.

Unused Locally Defined Annotations 16

The source BEL script contained the following list annotations, but no references to the following values. It is suggested to prune these values from the list definitions.

Note: this may be due to errors occurring in all statements with these annotations.

Annotation Values
BRCO
  • Striatum
  • Parietal_Lobe
  • Frontal_cortex
  • Hippocampus
  • Temporal_Lobe
  • Occipital_cortex
  • Cerebellum
Condition
  • Normal Healthy State
Confidence
  • high
  • low
  • medium
  • very low
Developmental_Phase__of_patient
  • Developmental stage
  • Old
  • Adult
  • Adolescence
  • Young
DiseaseState
  • Early-onset AD
  • Late-onset AD
  • Moderate AD
  • Pre-dementia
  • Mild AD
Duration_of_Chemical_Exposure
  • Chronic
  • Subchronic
Encode_Feature_Types
  • Promoter
  • Enhancer
  • CTCF
  • TF binding site
  • Open chromatin
  • Promoter Flanking Region
Experimental_Group
  • Sedentary group
  • Physical exercised group
FDASTATUS
  • Phase 2
  • Phase 3
  • Phase 1
  • Phase 2/3
  • Approved
  • Inactive
  • Phase 4
  • Discontinued
KnockoutMice
  • IDE KO mice
  • INSR knockout mice
  • LID mice
  • GLP1 KO mice
  • IRS1 KO mice
  • KO Mapk8ip1
  • IGF1 KO mice
  • NIRKO mice
  • App transgenic
  • IRS2 KO mice
NIFT
  • Volumetric MRI
  • Positron Emission Tomography
Patient
  • APOE e4 -ve
  • AD T2DM -ve
  • AD T2DM +ve
  • APOE e4 +ve
Race
  • Swedish
  • Colombian
  • White
  • silhouettes women
  • Chinese
  • non-Hispanic black
  • Black
  • Taiwanese
  • non-Hispanic white
  • Han Chinese in Taiwan
  • Han Chinese in Singapore
  • Hispanic
  • US women
  • Japanese
  • Caucasian
  • Italian
Transcriptionally_active_region
  • intron 1
  • 5 prime UTR
  • 3 prime UTR
  • exon 3
  • exon 41
UserdefinedCell
  • Beta cell
  • Astrocyte
  • Islets
UserdefinedCellLine
  • primary neuron
  • IDE APP transgenic
  • N2a695 cell
  • Neuroblastoma cell
  • App transgenic
  • 293APPwt
  • CHOAPPsw
  • primary cortical neuron
  • INS-1 cells
  • NT2N cells

Warning Statistics

Syntax Errors 20

Line BEL Message
2882 p(HGNC:BRAF) -| p(HGNC:TGFBRAP1,pmod(P,Serine)) General Parser Failure on line 2882 at pos 31: p(HGNC:BRAF) -| p(HGNC:TGFBRAP1,pmod(P,Serine))
2883 p(HGNC:TGFBRAP1,pmod(P,Serine)) -| bp(MESHPP:"Drug Resistance") General Parser Failure on line 2883 at pos 15: p(HGNC:TGFBRAP1,pmod(P,Serine)) -| bp(MESHPP:"Drug Resistance")
3036 a(SCHEM:"LY 294002") -| p(HGNC:AKT1,pmod(P,Serine,473)) General Parser Failure on line 3036 at pos 35: a(SCHEM:"LY 294002") -| p(HGNC:AKT1,pmod(P,Serine,473))
3848 composite(p(HGNC:FCGR2A sub(F,158,V)), a("Cetuximab")) causesNoChange bp("survival rate") General Parser Failure on line 3848 at pos 24: composite(p(HGNC:FCGR2A sub(F,158,V)), a("Cetuximab")) causesNoChange bp("survival rate")
4700 p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") General Parser Failure on line 4700 at pos 13: p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity")
4701 p(HGNC:FCGR3A, pmod(V,F,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") General Parser Failure on line 4701 at pos 13: p(HGNC:FCGR3A, pmod(V,F,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity")
4707 p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp("survival rate") General Parser Failure on line 4707 at pos 13: p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp("survival rate")
7157 path(MESHD:"Colorectal Neoplasms") -> (GOCC:"extracellular matrix component") General Parser Failure on line 7157 at pos 40: path(MESHD:"Colorectal Neoplasms") -> (GOCC:"extracellular matrix component")
7178 c(GOCC:"ribosome") -- g(HGNC:RPL13) General Parser Failure on line 7178 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL13)
7179 c(GOCC:"ribosome") -- g(HGNC:RPL27A) General Parser Failure on line 7179 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL27A)
7180 c(GOCC:"ribosome") -- g(HGNC:RPL4) General Parser Failure on line 7180 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL4)
7181 c(GOCC:"ribosome") -- g(HGNC:RPS18) General Parser Failure on line 7181 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPS18)
7182 c(GOCC:"ribosome") -- g(HGNC:RPS29) General Parser Failure on line 7182 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPS29)
10164 "Laterally spreading tumours (LSTs) are a heterogeneous group of adenomas that are emerging as important precursors of colorectal cancer and in which the risk for cancer is related to their endoscopically definable morphology." General Parser Failure on line 10164 at pos 0: "Laterally spreading tumours (LSTs) are a heterogeneous group of adenomas that are emerging as important precursors of colorectal cancer and in which the risk for cancer is related to their endoscopically definable morphology."
11590 a(CHEBI:"epidermal growth factor receptor antagonist") hasMember list(a(SCHEM:Cetuximab),a(SCHEM:Cetuximab)) General Parser Failure on line 11590 at pos 65: a(CHEBI:"epidermal growth factor receptor antagonist") hasMember list(a(SCHEM:Cetuximab),a(SCHEM:Cetuximab))
11778 g(HGNC:KRAS) biomarkerFor a("Treatment outcome") General Parser Failure on line 11778 at pos 26: g(HGNC:KRAS) biomarkerFor a("Treatment outcome")
11779 g(HGNC:NRAS) biomarkerFor a("Treatment outcome") General Parser Failure on line 11779 at pos 26: g(HGNC:NRAS) biomarkerFor a("Treatment outcome")
13118 g(HGNC:KRT20) biomarkerFor a("Survival Rate") General Parser Failure on line 13118 at pos 27: g(HGNC:KRT20) biomarkerFor a("Survival Rate")
13119 g(HGNC:BIRC5) biomarkerFor a("Survival Rate") General Parser Failure on line 13119 at pos 27: g(HGNC:BIRC5) biomarkerFor a("Survival Rate")
13209 g(HGNC:KRT20) biomarkerFor a("circulating tumor cells") General Parser Failure on line 13209 at pos 27: g(HGNC:KRT20) biomarkerFor a("circulating tumor cells")

All Parser Warnings 1483

A faceted table view of all parser warnings can be viewed and exported from here.

Line BEL Message
6 SET DOCUMENT Version = "1.1" Version string "1.1" neither is a date like YYYYMMDD nor adheres to semantic versioning. See http://semver.org/
283 a("Zuo Jin Wan") -| bp(GOBP:"cell growth") [pos:2] "Zuo Jin Wan" should be qualified with a valid namespace
288 a("Zuo Jin Wan") -| p(HGNC:ABCB1) [pos:2] "Zuo Jin Wan" should be qualified with a valid namespace
289 a("Zuo Jin Wan") -| bp(MESHPP:"Drug Resistance") [pos:2] "Zuo Jin Wan" should be qualified with a valid namespace
547 SET MeSHDisease = "SW620" "SW620" is not defined in the MeSHDisease annotation
549 complex(p(HGNC:CD44),p(HGNC:PROM1)) -- a("cancer stem cells") [pos:41] "cancer stem cells" should be qualified with a valid namespace
567 p(ZFIN:cd44a) negativeCorrelation path(MESHD:Neoplasms) 'g'
661 SET CellLine = "HT_29 cell" "HT_29 cell" is not defined in the CellLine annotation
673 SET Anatomy = "Colon" "Colon" is not defined in the Anatomy annotation
768 a("PX-478") -| p(HGNC:HIF1A) [pos:2] "PX-478" should be qualified with a valid namespace
769 complex(a(SCHEM:Cetuximab),a("PX-478")) -| bp(GOBP:"cell proliferation") [pos:29] "PX-478" should be qualified with a valid namespace
770 complex(a(SCHEM:Cetuximab),a("PX-478")) -| p(HGNC:KRAS,sub(G,12,V)) [pos:29] "PX-478" should be qualified with a valid namespace
1027 p(ZFIN:kita) -- path(MESHD:"Testicular Neoplasms") 'g'
1066 p(HGNC:EGFR) biomarkerFor path(MESHD:Head,and,Neck,Neoplasms) "Head" is not in the MESHD namespace
1079 a(thiazol) -| p(HGNC:EGFR) [pos:2] "thiazol" should be qualified with a valid namespace
1105 SET MeSHDisease = {"Multiple Myeloma","Lymphoma","Lung Carcinoma","Mesothelioma","Leukemya","Colorectal Neoplasms","Breast Neoplasms","Pancreatic Neoplasms"} "Lung Carcinoma" is not defined in the MeSHDisease annotation
1112 bp(GOBP:"hydroxymethylglutaryl_CoA reductase activity") -- bp(GOBP:"cell adhesion") "hydroxymethylglutaryl_CoA reductase activity" is not in the GOBP namespace
1142 a("miR-221") -| p(HGNC:ETS1) [pos:2] "miR-221" should be qualified with a valid namespace
1143 a("miR-221") -| p(HGNC:STAT5A) [pos:2] "miR-221" should be qualified with a valid namespace
1144 a("miR-221") -| p(HGNC:KIT) [pos:2] "miR-221" should be qualified with a valid namespace
1148 r("miR-29a") -| p(HGNC:KLF4) [pos:2] "miR-29a" should be qualified with a valid namespace
1151 r("miR-29a") biomarkerFor path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-29a" should be qualified with a valid namespace
1152 r("miR-221") biomarkerFor path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-221" should be qualified with a valid namespace
1157 r("miR-143") -| p(HGNC:KRAS) [pos:2] "miR-143" should be qualified with a valid namespace
1161 r("miR-143") -| p(HGNC:MACC1) [pos:2] "miR-143" should be qualified with a valid namespace
1164 r("miR-143") biomarkerFor path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-143" should be qualified with a valid namespace
1169 r("miR-423") biomarkerFor path(MESHD:"Neoplasm Metastasis") [pos:2] "miR-423" should be qualified with a valid namespace
1170 r("miR-608") biomarkerFor path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-608" should be qualified with a valid namespace
1174 r("pre-miR-34a") -| p(HGNC:AXL) [pos:2] "pre-miR-34a" should be qualified with a valid namespace
1178 r("pre-miR-199a") -| p(HGNC:AXL) [pos:2] "pre-miR-199a" should be qualified with a valid namespace
1179 r("pre-miR-34a") -| path(MESHD:"Neoplasm Metastasis") [pos:2] "pre-miR-34a" should be qualified with a valid namespace
1180 r("pre-miR-199a") -| path(MESHD:"Neoplasm Metastasis") [pos:2] "pre-miR-199a" should be qualified with a valid namespace
1185 r("miR-328") -| p(HGNC:ABCG2) [pos:2] "miR-328" should be qualified with a valid namespace
1186 r("miR-222") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-222" should be qualified with a valid namespace
1187 r("miR-222") -| p(HGNC:ADAM17) [pos:2] "miR-222" should be qualified with a valid namespace
1188 r("miR-328") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-328" should be qualified with a valid namespace
1294 r("miR-145") -| p(HGNC:RAD18) [pos:2] "miR-145" should be qualified with a valid namespace
1295 r("miR-145") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-145" should be qualified with a valid namespace
1302 SET Eco = "Neoplasms" "Neoplasms" is not defined in the Eco annotation
1305 p(HGNC:RAD18) -- bp(GOBP:"ubiquitin_protein ligase activity") "ubiquitin_protein ligase activity" is not in the GOBP namespace
1320 r("miR-145") negativeCorrelation r(HGNC:RAD18) [pos:2] "miR-145" should be qualified with a valid namespace
1324 r("miR-145") -| (p(HGNC:RAD18) -> bp(MESHPP:"DNA Damage")) [pos:2] "miR-145" should be qualified with a valid namespace
1325 r("miR-145") -> bp(MESHPP:"DNA Damage") [pos:2] "miR-145" should be qualified with a valid namespace
1329 r("miR-145") -| p(HGNC:RAD18) [pos:2] "miR-145" should be qualified with a valid namespace
1333 r("miR-145") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-145" should be qualified with a valid namespace
1337 a("miR-145") -| p(HGNC:RAD18) [pos:2] "miR-145" should be qualified with a valid namespace
1497 complex(a("PKD inhibitor"),a(regorafenib)) -> bp(GOBP:"apoptotic process") [pos:10] "PKD inhibitor" should be qualified with a valid namespace
1498 complex(a("PKD inhibitor"),a(regorafenib)) -| p(HGNC:HSPB2) [pos:10] "PKD inhibitor" should be qualified with a valid namespace
1499 complex(a("PKD inhibitor"),a(regorafenib)) -> bp(CHEBI:"poly(ADP-ribose) polymerase inhibitor") [pos:10] "PKD inhibitor" should be qualified with a valid namespace
1504 complex(a("PKD inhibitor"),a(regorafenib)) -| p(HGNC:AKT1) [pos:10] "PKD inhibitor" should be qualified with a valid namespace
1505 complex(a("PKD inhibitor"),a(regorafenib)) -| p(HGNC:NFKB1) [pos:10] "PKD inhibitor" should be qualified with a valid namespace
1580 p(HGNC:MYC) -> r(CDKN1B) [pos:17] "CDKN1B" should be qualified with a valid namespace
1598 p(ZFIN:taz) -- bp(GOBP:"cell proliferation") 'g'
1600 path(MESHD:Neoplasms) -- p(ZFIN:taz) 'g'
1625 p(HGNC:KRAS,sub(G,12,V)) -- r("miR-4689") [pos:30] "miR-4689" should be qualified with a valid namespace
1629 r("miR-4689") -| bp(GOBP:"cell growth") [pos:2] "miR-4689" should be qualified with a valid namespace
1630 r("miR-4689") -> bp(GOBP:"apoptotic process") [pos:2] "miR-4689" should be qualified with a valid namespace
1635 r("miR-4689") -| p(HGNC:AKT1) [pos:2] "miR-4689" should be qualified with a valid namespace
1639 r("miR-4689") -- bp(GOBP:"epidermal growth factor receptor activity") [pos:2] "miR-4689" should be qualified with a valid namespace
1643 r("miR-4689") -| bp(MESHPP:"MAP Kinase Signaling System") [pos:2] "miR-4689" should be qualified with a valid namespace
1647 r("miR-4689") -| bp(GOBP:"phosphatidylinositol 3_kinase activity") [pos:2] "miR-4689" should be qualified with a valid namespace
1799 complex(a(Cryotherapy),a(CHEBI:adjuvant)) -> bp(GOBP:"apoptotic process") [pos:10] "Cryotherapy" should be qualified with a valid namespace
1800 complex(a(Cryotherapy),a(CHEBI:adjuvant)) -> bp(GOBP:"cell death") [pos:10] "Cryotherapy" should be qualified with a valid namespace
1804 complex(a(Cryotherapy),a(CHEBI:adjuvant),a(SCHEM:"Caspase inhibitor")) -| bp(GOBP:"apoptotic process") [pos:10] "Cryotherapy" should be qualified with a valid namespace
1808 complex(a(Cryotherapy),a(CHEBI:adjuvant)) -> p(HGNC:BAX) [pos:10] "Cryotherapy" should be qualified with a valid namespace
1813 complex(a(Cryotherapy),a(CHEBI:adjuvant)) -> bp(GOBP:"apoptotic process") [pos:10] "Cryotherapy" should be qualified with a valid namespace
1842 SET MeSHDisease = "DNA microarray" "DNA microarray" is not defined in the MeSHDisease annotation
1870 SET Disease = "HCT116" "HCT116" is not defined in the Disease annotation
2137 a(SFRE) -> a(CHEBI:"5-fluorouracil") [pos:2] "SFRE" should be qualified with a valid namespace
2141 a(SFRE) -| bp(MESHPP:"Drug Resistance") [pos:2] "SFRE" should be qualified with a valid namespace
2145 a(SFRE) -| p(HGNC:TK1) [pos:2] "SFRE" should be qualified with a valid namespace
2146 a(SFRE) -| p(HGNC:TYMS) [pos:2] "SFRE" should be qualified with a valid namespace
2157 a(HGNC:PDK3) -> bp(MESHPP:"Drug Resistance") Abundance HGNC:PDK3 should be encoded as one of: miRNA, Gene, RNA, Protein
2261 complex(p(HGNC:EGFR),a(panitumumab)) [pos:23] "panitumumab" should be qualified with a valid namespace
2272 a("miR-128") -> bp(MESHPP:"DNA Damage") [pos:2] "miR-128" should be qualified with a valid namespace
2276 a("miR-21") -- path(MESHD:"Carcinoma, Squamous Cell") [pos:2] "miR-21" should be qualified with a valid namespace
2277 a("miR-106b") -- path(MESHD:"Carcinoma, Squamous Cell") [pos:2] "miR-106b" should be qualified with a valid namespace
2281 a("miR-375") -- path(MESHD:"Carcinoma, Squamous Cell") [pos:2] "miR-375" should be qualified with a valid namespace
2320 SET CellLine = "Caco_2 cell" "Caco_2 cell" is not defined in the CellLine annotation
2380 a(hypermethylation) -| r(HGNC:TFAP2E) [pos:2] "hypermethylation" should be qualified with a valid namespace
2399 SET CellLine = {"SW620","HCT15","WiDr"} "WiDr" is not defined in the CellLine annotation
2412 a(SCHEM:"SN 38") -> p(ZFIN:top1) 'g'
2472 a(CHEBI:sulindac) -| tloc(p(HGNC:CTNNB1)) [pos:25] Unqualified translocation: a(CHEBI:sulindac) -| tloc(p(HGNC:CTNNB1)) [['Protein', 'HGNC', 'CTNNB1']]
2505 a(thiazolides) -> bp(GOBP:"apoptotic process") [pos:2] "thiazolides" should be qualified with a valid namespace
2510 a(thiazolides) -> p(HGNC:MAPK9) [pos:2] "thiazolides" should be qualified with a valid namespace
2511 a(thiazolides) -> p(HGNC:MAPK14) [pos:2] "thiazolides" should be qualified with a valid namespace
2512 a(thiazolides) -> (p(HGNC:MAPK9) -> bp(GOBP:"cell death")) [pos:2] "thiazolides" should be qualified with a valid namespace
2513 a(thiazolides) -> (p(HGNC:MAPK14) -> bp(GOBP:"cell death")) [pos:2] "thiazolides" should be qualified with a valid namespace
2540 a(thiazolide) -> kin(p(HGNC:MAPK9)) [pos:2] "thiazolide" should be qualified with a valid namespace
2541 a(thiazolide) -> p(HGNC:BCL2L11) [pos:2] "thiazolide" should be qualified with a valid namespace
2599 complex(a(CHEBI:"5-fluorouracil"),a(SC144)) -| bp(GOBP:"cell growth") [pos:36] "SC144" should be qualified with a valid namespace
2603 complex(a(CHEBI:oxaliplatin),a(SC144)) -| bp(GOBP:"cell growth") [pos:31] "SC144" should be qualified with a valid namespace
2609 complex(a(SC144),a(SCHEM:Paclitaxel)) -| bp(GOBP:"cell growth") [pos:10] "SC144" should be qualified with a valid namespace
2616 complex(a(SC144),a(SCHEM:Paclitaxel)) -| bp(GOBP:"cell growth") [pos:10] "SC144" should be qualified with a valid namespace
2676 bp(GOBP:"histone deacetylase inhibitor activity") -- bp(GOBP:"apoptotic process") "histone deacetylase inhibitor activity" is not in the GOBP namespace
2683 a(LBH589) -| p(HGNC:AKT1) [pos:2] "LBH589" should be qualified with a valid namespace
2710 r("miR-17-5p") -> path(MESHD:"Neoplasm Metastasis") [pos:2] "miR-17-5p" should be qualified with a valid namespace
2714 r("miR-17-5p") -> bp(MESHPP:"Drug Resistance") [pos:2] "miR-17-5p" should be qualified with a valid namespace
2715 r("miR-17-5p") -| p(HGNC:PTEN) [pos:2] "miR-17-5p" should be qualified with a valid namespace
2720 r("miR-17-5p") -> bp(GOBP:"cell invasion") [pos:2] "miR-17-5p" should be qualified with a valid namespace
2731 r("miR-34a") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-34a" should be qualified with a valid namespace
2732 r("miR-34a") -| p(HGNC:SIRT1) [pos:2] "miR-34a" should be qualified with a valid namespace
2733 r("miR-34a") -| p(HGNC:E2F3) [pos:2] "miR-34a" should be qualified with a valid namespace
2739 r("miR-34a") -| path(MESHD:"Neoplasm Metastasis") [pos:2] "miR-34a" should be qualified with a valid namespace
2740 r("miR-34a") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-34a" should be qualified with a valid namespace
2744 r("miR-34a") -| path(MESHD:"Neoplasms") [pos:2] "miR-34a" should be qualified with a valid namespace
2821 p(HGNC:HMGB1) -> bp(GOBP:"vascular endothelial growth factor receptor binding") "vascular endothelial growth factor receptor binding" is not in the GOBP namespace
2882 p(HGNC:BRAF) -| p(HGNC:TGFBRAP1,pmod(P,Serine)) General Parser Failure on line 2882 at pos 31: p(HGNC:BRAF) -| p(HGNC:TGFBRAP1,pmod(P,Serine))
2883 p(HGNC:TGFBRAP1,pmod(P,Serine)) -| bp(MESHPP:"Drug Resistance") General Parser Failure on line 2883 at pos 15: p(HGNC:TGFBRAP1,pmod(P,Serine)) -| bp(MESHPP:"Drug Resistance")
2929 a(SCHEM:"SN 38") -| p(ZFIN:top1) 'g'
3002 a(EHT6706) -- bp(MESHPP:Polymerization) [pos:2] "EHT6706" should be qualified with a valid namespace
3003 a(EHT6706) -| a(GOCC:microtubule) [pos:2] "EHT6706" should be qualified with a valid namespace
3004 a(SCHEM:Colchicine) -| a(GOCC:microtubule) Abundance GOCC:microtubule should be encoded as one of: Complex
3010 a(EHT6706) -| bp(GOBP:"cell growth") [pos:2] "EHT6706" should be qualified with a valid namespace
3015 a(EHT6706) -| bp(GOBP:"cell migration") [pos:2] "EHT6706" should be qualified with a valid namespace
3019 a(EHT6706) -| bp(GOBP:angiogenesis) [pos:2] "EHT6706" should be qualified with a valid namespace
3030 a(ZJW) -| p(SFAM:"AKT Family") [pos:2] "ZJW" should be qualified with a valid namespace
3031 a(ZJW) -| p(HGNC:NFKB1) [pos:2] "ZJW" should be qualified with a valid namespace
3032 a(ZJW) -| bp(MESHPP:"Drug Resistance") [pos:2] "ZJW" should be qualified with a valid namespace
3036 a(SCHEM:"LY 294002") -| p(HGNC:AKT1,pmod(P,Serine,473)) General Parser Failure on line 3036 at pos 35: a(SCHEM:"LY 294002") -| p(HGNC:AKT1,pmod(P,Serine,473))
3037 a(ZJW) -| p(HGNC:NFKB1,pmod(P,Serine,473)) [pos:2] "ZJW" should be qualified with a valid namespace
3039 a(ZJW) -| p(HGNC:NFKB1,pmod(P)) [pos:2] "ZJW" should be qualified with a valid namespace
3063 composite(a(CHEBI:parthenolide),a(CHEBI:"5-fluorouracil")) -> tloc(p(HGNC:CYCS)) [pos:66] Unqualified translocation: composite(a(CHEBI:parthenolide),a(CHEBI:"5-fluorouracil")) -> tloc(p(HGNC:CYCS)) [['Protein', 'HGNC', 'CYCS']]
3122 a(PZH) -| bp(GOBP:"cell proliferation") [pos:2] "PZH" should be qualified with a valid namespace
3123 a(PZH) -| bp(GOBP:"cell growth") [pos:2] "PZH" should be qualified with a valid namespace
3124 a(PZH) -> bp(GOBP:"apoptotic process") [pos:2] "PZH" should be qualified with a valid namespace
3129 a(PZH) -| bp(GOBP:angiogenesis) [pos:2] "PZH" should be qualified with a valid namespace
3135 a(PHZ) -| bp(GOBP:"cell growth") [pos:2] "PHZ" should be qualified with a valid namespace
3139 a(PHZ) -| p(HGNC:ABCG2) [pos:2] "PHZ" should be qualified with a valid namespace
3140 a(PHZ) -| p(HGNC:ABCB1) [pos:2] "PHZ" should be qualified with a valid namespace
3151 bp(GOBP:"cell proliferation") -- a("cancer stem cells") [pos:35] "cancer stem cells" should be qualified with a valid namespace
3155 bp(MESHPP:"Drug Resistance") -- a("cancer stem cells") [pos:34] "cancer stem cells" should be qualified with a valid namespace
3160 r("miR-451") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-451" should be qualified with a valid namespace
3164 r("miR-451") -| bp(GOBP:"cell growth") [pos:2] "miR-451" should be qualified with a valid namespace
3172 a("miR-451") -- p(HGNC:PTGS2) [pos:2] "miR-451" should be qualified with a valid namespace
3178 r("miR-451") -> p(HGNC:MIF) [pos:2] "miR-451" should be qualified with a valid namespace
3186 r("miR-451") -| p(HGNC:ABCB1) [pos:2] "miR-451" should be qualified with a valid namespace
3197 a(Dbait) -| bp(GOBP:"DNA repair") [pos:2] "Dbait" should be qualified with a valid namespace
3203 a(Dbait) -| bp(MESHPP:"Drug Resistance") [pos:2] "Dbait" should be qualified with a valid namespace
3210 a(Dbait) -> (complex(a(SCHEM:Oxaliplatin),a(SCHEM:"5-fluorouracil")) -| path(MESHD:"Colorectal Neoplasms")) [pos:2] "Dbait" should be qualified with a valid namespace
3215 a(Dbait) -| bp(GOBP:angiogenesis) [pos:2] "Dbait" should be qualified with a valid namespace
3216 a(Dbait) -> bp(GOBP:"necrotic cell death") [pos:2] "Dbait" should be qualified with a valid namespace
3217 a(Dbait) -> bp(GOBP:"apoptotic process") [pos:2] "Dbait" should be qualified with a valid namespace
3218 a(Dbait) -| bp(GOBP:"cell proliferation") [pos:2] "Dbait" should be qualified with a valid namespace
3240 SET MeSHDisease = "MESHD:\"Liver Neoplasms\"" "MESHD:\"Liver Neoplasms\"" is not defined in the MeSHDisease annotation
3246 bp(GOBP:"aldehyde reductase activity") positiveCorrelation path(MESHD:Neoplasms) "aldehyde reductase activity" is not in the GOBP namespace
3267 r("miR-203") -| p(HGNC:ATM) [pos:2] "miR-203" should be qualified with a valid namespace
3271 r("miR-203") -> bp(MESHPP:"Drug Resistance") [pos:2] "miR-203" should be qualified with a valid namespace
3275 r("miR-203") -- bp(MESHPP:"Drug Resistance") [pos:2] "miR-203" should be qualified with a valid namespace
3299 r("miR-203") -| p(HGNC:ATM) [pos:2] "miR-203" should be qualified with a valid namespace
3300 r("miR-203") -> bp(MESHPP:"Drug Resistance") [pos:2] "miR-203" should be qualified with a valid namespace
3316 p(HGNC:KRAS) -- path(MESHD:"Drug Resistance") "Drug Resistance" is not in the MESHD namespace
3335 p(HGNC:CXCR4) -- a(Endostar) [pos:19] "Endostar" should be qualified with a valid namespace
3339 p(HGNC:HIF1A) -- a(Endostar) [pos:19] "Endostar" should be qualified with a valid namespace
3340 p(HGNC:EPAS1) -- a(Endostar) [pos:19] "Endostar" should be qualified with a valid namespace
3344 composite(a(endostar),a(CHEBI:oxaliplatin)) -| bp(GOBP:"cell adhesion") [pos:12] "endostar" should be qualified with a valid namespace
3345 composite(a(endostar),a(CHEBI:oxaliplatin)) -| bp(GOBP:"cell proliferation") [pos:12] "endostar" should be qualified with a valid namespace
3346 composite(a(endostar),a(CHEBI:oxaliplatin)) -| (r(HGNC:CXCR4) -| bp(GOBP:"cell adhesion")) [pos:12] "endostar" should be qualified with a valid namespace
3347 composite(a(endostar),a(CHEBI:oxaliplatin)) -| (r(HGNC:CXCR4) -| bp(GOBP:"cell proliferation")) [pos:12] "endostar" should be qualified with a valid namespace
3352 composite(a(endostar),a(CHEBI:oxaliplatin)) -| r(HGNC:CXCR4) [pos:12] "endostar" should be qualified with a valid namespace
3364 a(endostar) -| p(HGNC:CXCR4) [pos:2] "endostar" should be qualified with a valid namespace
3365 a(endostar) -| p(HGNC:EPAS1) [pos:2] "endostar" should be qualified with a valid namespace
3371 a(endostar) -| bp(MESHPP:"Drug Resistance") [pos:2] "endostar" should be qualified with a valid namespace
3414 SET Anatomy = "Serum" "Serum" is not defined in the Anatomy annotation
3416 SET MeSHDisease = "Colorectal Neoplsms" "Colorectal Neoplsms" is not defined in the MeSHDisease annotation
3432 path(MESHD:"Colorectal Neoplasms") -- p(HGNC:"COMMD3-BMI1") Protein HGNC:COMMD3-BMI1 should be encoded as one of: miRNA, Gene, RNA
3511 r(miRNA) -| p(HGNC:PEBP1) [pos:2] "miRNA" should be qualified with a valid namespace
3622 a(CHEBI:fingolimod) -> bp(GOBP:"autophagic vacuole assembly") "autophagic vacuole assembly" is not in the GOBP namespace
3747 r("miR-328") -- path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-328" should be qualified with a valid namespace
3751 r("miR-328") -| bp(MESHPP:"Drug Resistance") [pos:2] "miR-328" should be qualified with a valid namespace
3755 r("miR-328") -| p(HGNC:ABCG2) [pos:2] "miR-328" should be qualified with a valid namespace
3759 r("miR-328") -| p(HGNC:MMP16) [pos:2] "miR-328" should be qualified with a valid namespace
3780 p(HGNC:EGFR) -> a("PF-04691502") [pos:18] "PF-04691502" should be qualified with a valid namespace
3785 a("PF-04691502") -> p(HGNC:EGFR) [pos:2] "PF-04691502" should be qualified with a valid namespace
3786 a("PF-04691502") -> p(HGNC:ERBB2) [pos:2] "PF-04691502" should be qualified with a valid namespace
3787 a("PF-04691502") -> p(HGNC:ERBB3) [pos:2] "PF-04691502" should be qualified with a valid namespace
3788 a("PF-04691502") -> p(HGNC:FOXO3) [pos:2] "PF-04691502" should be qualified with a valid namespace
3790 bp(GOBP:"phosphatidylinositol-3 kinase activity") -| p(HGNC:FOXO3) "phosphatidylinositol-3 kinase activity" is not in the GOBP namespace
3791 a("PF-04691502") -> (p(HGNC:FOXO3) -> p(HGNC:EGFR)) [pos:2] "PF-04691502" should be qualified with a valid namespace
3792 a("PF-04691502") -> (p(HGNC:FOXO3) -> p(HGNC:ERBB2)) [pos:2] "PF-04691502" should be qualified with a valid namespace
3793 a("PF-04691502") -> (p(HGNC:FOXO3) -> p(HGNC:ERBB3)) [pos:2] "PF-04691502" should be qualified with a valid namespace
3799 a("PF-04691502") -> p(HGNC:EGFR) [pos:2] "PF-04691502" should be qualified with a valid namespace
3805 a(dacomitinib) -| p(HGNC:EGFR) [pos:2] "dacomitinib" should be qualified with a valid namespace
3832 SET Trial = "NCIC CTG CO.17" "Trial" is not defined
3839 g(dbSNP:rs1801274) -> p(HGNC:FCGR2A, sub(H,131,R)) "dbSNP" is not a defined namespace
3840 p(HGNC:FCGR2A, sub(H,131,R)) -- a("Cetuximab related outcomes") [pos:34] "Cetuximab related outcomes" should be qualified with a valid namespace
3841 p(HGNC:FCGR3A, sub(F,158,V)) -- a("Cetuximab related outcomes") [pos:34] "Cetuximab related outcomes" should be qualified with a valid namespace
3847 composite(p(HGNC:FCGR2A), a("Cetuximab")) -> bp("survival rate") [pos:28] "Cetuximab" should be qualified with a valid namespace
3848 composite(p(HGNC:FCGR2A sub(F,158,V)), a("Cetuximab")) causesNoChange bp("survival rate") General Parser Failure on line 3848 at pos 24: composite(p(HGNC:FCGR2A sub(F,158,V)), a("Cetuximab")) causesNoChange bp("survival rate")
3890 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
3916 SET Trial = "GOG 182" "Trial" is not defined
3923 path(DO:"ovarian mucinous neoplasm") -| a("surviva rate") [pos:42] "surviva rate" should be qualified with a valid namespace
3946 composite(a(CHEBI:"oxaliplatin"), a("Cetuximab")) -| path(MESHD:"Colorectal Neoplasms") [pos:36] "Cetuximab" should be qualified with a valid namespace
3959 a("neoadjuvant") -> bp("survival rate") [pos:2] "neoadjuvant" should be qualified with a valid namespace
3971 a("Bevacizumab") -| path(MESHD:"Neoplasms") [pos:2] "Bevacizumab" should be qualified with a valid namespace
3979 composite(a(CHEBI:"lenalidomide"),a("Bevacizumab")) -| path(MESHD:"Neoplasms") [pos:36] "Bevacizumab" should be qualified with a valid namespace
3980 composite(a(CHEBI:"lenalidomide"),a("Bevacizumab")) causesNoChange path("Drug Toxicity") [pos:36] "Bevacizumab" should be qualified with a valid namespace
3990 a("FOLFIRI") hasMember list(a(CHEBI:"Calcium folinate"), a(CHEBI:"5-fluorouracil"), a(CHEBI:"irinotecan")) [pos:2] "FOLFIRI" should be qualified with a valid namespace
3991 composite(a("Bevacizumab"),a("FOLFIRI")) -> bp("survival rate") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4003 a("FOLFOX") hasMember list(a(CHEBI:"Calcium folinate"), a(CHEBI:"5-fluorouracil"), a(CHEBI:"oxaliplatin")) [pos:2] "FOLFOX" should be qualified with a valid namespace
4004 composite(a("Bevacizumab"),a("FOLFOX")) -> bp("survival rate") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4010 composite(a("Bevacizumab"),a("FOLFOX")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4022 SET TisueType = "non-cancerous" "TisueType" is not defined
4024 a("FOLFOX") -> a("Chemoresistance") [pos:2] "FOLFOX" should be qualified with a valid namespace
4025 a("FOLFIRI") -> a("Chemoresistance") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4038 a("loaded liposomes") hasMember list(a(CHEBI:"Calcium folinate"), a(CHEBI:"oxaliplatin"), a(CHEBI:"5-fluorouracil"), a("5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrin")) [pos:2] "loaded liposomes" should be qualified with a valid namespace
4040 a("loaded liposomes") -| bp(GOBP:"cell growth") [pos:2] "loaded liposomes" should be qualified with a valid namespace
4045 a("drug encapsulation") -| a("Chemoresistance") [pos:2] "drug encapsulation" should be qualified with a valid namespace
4057 g(HGNC:KRAS) biomarkerFor bp("anti-EGFR therapy resistance") [pos:29] "anti-EGFR therapy resistance" should be qualified with a valid namespace
4058 g(HGNC:NRAS) biomarkerFor bp("anti-EGFR therapy resistance") [pos:29] "anti-EGFR therapy resistance" should be qualified with a valid namespace
4063 p(HGNC:BRAF, sub(V,600,E)) biomarkerFor bp("patient prognosis") [pos:43] "patient prognosis" should be qualified with a valid namespace
4068 g(HGNC:UGT1A1) biomarkerFor path("Drug Toxicity") [pos:33] "Drug Toxicity" should be qualified with a valid namespace
4079 composite(a(CHEBI:"oxaliplatin"), a(CHEBI:"5-fluorouracil")) -> a("hematologic event") [pos:66] "hematologic event" should be qualified with a valid namespace
4080 composite(a(CHEBI:"oxaliplatin"), a(CHEBI:"5-fluorouracil")) -> a("grade 3 hematologic toxicity") [pos:66] "grade 3 hematologic toxicity" should be qualified with a valid namespace
4092 a("CapOx") hasMember list(a(CHEBI:"capecitabine"),a(CHEBI:"oxaliplatin")) [pos:2] "CapOx" should be qualified with a valid namespace
4093 a("CapOx") -| path("neuropathy") [pos:2] "CapOx" should be qualified with a valid namespace
4094 a("FOLFOX") -| path("neuropathy") [pos:2] "FOLFOX" should be qualified with a valid namespace
4095 a("FOLFIRI") -| path("neuropathy") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4114 a("ruthenacycles") -| bp(GOBP:"cell growth") [pos:2] "ruthenacycles" should be qualified with a valid namespace
4119 a("ruthenacycles") -> sec(p(HGNC:IFNG)) [pos:2] "ruthenacycles" should be qualified with a valid namespace
4120 a("ruthenacycles") -| sec(p(HGNC:CCL5)) [pos:2] "ruthenacycles" should be qualified with a valid namespace
4121 a("ruthenacycles") -| sec(p(HGNC:IGF1)) [pos:2] "ruthenacycles" should be qualified with a valid namespace
4126 a("ruthenacycles") -- p(RPS21) [pos:2] "ruthenacycles" should be qualified with a valid namespace
4127 a("ruthenacycles") -- bp(GOBP:"regulation of cytokine secretion") [pos:2] "ruthenacycles" should be qualified with a valid namespace
4139 a("Bevacizumab") -> bp("survival rate") [pos:2] "Bevacizumab" should be qualified with a valid namespace
4140 a("Aflibercept") -> bp("survival rate") [pos:2] "Aflibercept" should be qualified with a valid namespace
4141 a(CHEBI:regorafenib) -> bp("survival rate") [pos:27] "survival rate" should be qualified with a valid namespace
4142 a("Ramucirumab") -> bp("survival rate") [pos:2] "Ramucirumab" should be qualified with a valid namespace
4147 a("Fruquintinib") -> bp("survival rate") #On PubChem [pos:2] "Fruquintinib" should be qualified with a valid namespace
4148 a("Famitinib") -> bp("survival rate") #On PubChem [pos:2] "Famitinib" should be qualified with a valid namespace
4149 a("nintedanib") -> bp("survival rate") #On PubChem [pos:2] "nintedanib" should be qualified with a valid namespace
4154 a("VGX-100") =| p(HGNC:VEGFC)) [pos:2] "VGX-100" should be qualified with a valid namespace
4155 composite(a("VGX-100"),a("bevacizumab")) =| p(HGNC:KDR) [pos:12] "VGX-100" should be qualified with a valid namespace
4156 composite(a("VGX-100"),a("bevacizumab")) =| p(HGNC:FLT4) [pos:12] "VGX-100" should be qualified with a valid namespace
4161 a("tanibirumab") =| p(HGNC:KDR) [pos:2] "tanibirumab" should be qualified with a valid namespace
4162 a("vanucizumab") =| p(HGNC:VEGFA) [pos:2] "vanucizumab" should be qualified with a valid namespace
4163 a("vanucizumab") =| p(HGNC:ANGPT2) [pos:2] "vanucizumab" should be qualified with a valid namespace
4176 a("MM-1151") -| bp(GOBP:"cell growth") [pos:2] "MM-1151" should be qualified with a valid namespace
4177 a("MM-1151") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "MM-1151" should be qualified with a valid namespace
4178 a("MM-1151") -| path(MESHD:"Neoplasm Invasiveness") [pos:2] "MM-1151" should be qualified with a valid namespace
4179 a("MM-1151") -| a("Cetuximab resistance") [pos:2] "MM-1151" should be qualified with a valid namespace
4192 a("Cetuximab") -| bp(GOBP:"epidermal growth factor receptor signaling pathway") [pos:2] "Cetuximab" should be qualified with a valid namespace
4193 a("panitumumab") -| bp(GOBP:"epidermal growth factor receptor signaling pathway") [pos:2] "panitumumab" should be qualified with a valid namespace
4195 a("Cetuximab") -- p(HGNC:KRAS) [pos:2] "Cetuximab" should be qualified with a valid namespace
4196 a("panitumumab") -- p(HGNC:KRAS) [pos:2] "panitumumab" should be qualified with a valid namespace
4212 composite(a(CHEBI:"5-fluorouracil"), a(CHEBI:"capecitabine")) -| a("mortality") [pos:67] "mortality" should be qualified with a valid namespace
4217 composite(a(CHEBI:"5-fluorouracil"), a(CHEBI:"capecitabine")) causesNoChange a("mortality") [pos:79] "mortality" should be qualified with a valid namespace
4228 p(HGNC:TP53) -> a("p53 antibody") [pos:18] "p53 antibody" should be qualified with a valid namespace
4234 a("p53 antibody") biomarkerFor path(MESHD:"colorectal cancer") [pos:2] "p53 antibody" should be qualified with a valid namespace
4240 a("FOLFOX"), a("Bevacizumab") -| a("CEA") [pos:2] "FOLFOX" should be qualified with a valid namespace
4241 a("FOLFOX"), a("Bevacizumab") -| a("CA19-9") [pos:2] "FOLFOX" should be qualified with a valid namespace
4247 a("FOLFOX"), a("Bevacizumab") -| a("p53 antibody") [pos:2] "FOLFOX" should be qualified with a valid namespace
4252 a("p53 antibody") biomarkerFor path("tumor recurrence") [pos:2] "p53 antibody" should be qualified with a valid namespace
4263 composite(a(CHEBI:"oxaliplatin"),a("traditional plant-based medicines")) -| path(MESHD:"Nausea") [pos:35] "traditional plant-based medicines" should be qualified with a valid namespace
4264 composite(a(CHEBI:"oxaliplatin"),a("traditional plant-based medicines")) -| path(MESHD:"Vomoting") [pos:35] "traditional plant-based medicines" should be qualified with a valid namespace
4276 a("Atractylodes macrocephala") -| path(MESHD:"Nausea") [pos:2] "Atractylodes macrocephala" should be qualified with a valid namespace
4277 a("Atractylodes macrocephala") -| path(MESHD:"Vomiting") [pos:2] "Atractylodes macrocephala" should be qualified with a valid namespace
4278 a("Atractylodes macrocephala") -> bp(GOBP:"antioxidant activity") [pos:2] "Atractylodes macrocephala" should be qualified with a valid namespace
4279 a("Atractylodes macrocephala") -> bp("gastroprotective effects") [pos:2] "Atractylodes macrocephala" should be qualified with a valid namespace
4280 a("Atractylodes macrocephala") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Atractylodes macrocephala" should be qualified with a valid namespace
4281 a("Poria cocos") -| path(MESHD:"Nausea") [pos:2] "Poria cocos" should be qualified with a valid namespace
4282 a("Poria cocos") -| path(MESHD:"Vomiting") [pos:2] "Poria cocos" should be qualified with a valid namespace
4283 a("Poria cocos") -> bp(GOBP:"antioxidant activity") [pos:2] "Poria cocos" should be qualified with a valid namespace
4284 a("Poria cocos") -> bp("gastroprotective effects") [pos:2] "Poria cocos" should be qualified with a valid namespace
4285 a("Poria cocos") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Poria cocos" should be qualified with a valid namespace
4286 a("Coix lacryma-jobi") -| path(MESHD:"Nausea") [pos:2] "Coix lacryma-jobi" should be qualified with a valid namespace
4287 a("Coix lacryma-jobi") -| path(MESHD:"Vomiting") [pos:2] "Coix lacryma-jobi" should be qualified with a valid namespace
4288 a("Coix lacryma-jobi") -> bp(GOBP:"antioxidant activity") [pos:2] "Coix lacryma-jobi" should be qualified with a valid namespace
4289 a("Coix lacryma-jobi") -> bp("gastroprotective effects") [pos:2] "Coix lacryma-jobi" should be qualified with a valid namespace
4290 a("Coix lacryma-jobi") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Coix lacryma-jobi" should be qualified with a valid namespace
4291 a("Astragalus membranaceus") -| path(MESHD:"Nausea") [pos:2] "Astragalus membranaceus" should be qualified with a valid namespace
4292 a("Astragalus membranaceus") -| path(MESHD:"Vomiting") [pos:2] "Astragalus membranaceus" should be qualified with a valid namespace
4293 a("Astragalus membranaceus") -> bp(GOBP:"antioxidant activity") [pos:2] "Astragalus membranaceus" should be qualified with a valid namespace
4294 a("Astragalus membranaceus") -> bp("gastroprotective effects") [pos:2] "Astragalus membranaceus" should be qualified with a valid namespace
4295 a("Astragalus membranaceus") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Astragalus membranaceus" should be qualified with a valid namespace
4296 a("Glycyrrhiza uralensis") -| path(MESHD:"Nausea") [pos:2] "Glycyrrhiza uralensis" should be qualified with a valid namespace
4297 a("Glycyrrhiza uralensis") -| path(MESHD:"Vomiting") [pos:2] "Glycyrrhiza uralensis" should be qualified with a valid namespace
4298 a("Glycyrrhiza uralensis") -> bp(GOBP:"antioxidant activity") [pos:2] "Glycyrrhiza uralensis" should be qualified with a valid namespace
4299 a("Glycyrrhiza uralensis") -> bp("gastroprotective effects") [pos:2] "Glycyrrhiza uralensis" should be qualified with a valid namespace
4300 a("Glycyrrhiza uralensis") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Glycyrrhiza uralensis" should be qualified with a valid namespace
4301 a("Panax ginseng") -| path(MESHD:"Nausea") [pos:2] "Panax ginseng" should be qualified with a valid namespace
4302 a("Panax ginseng") -| path(MESHD:"Vomiting") [pos:2] "Panax ginseng" should be qualified with a valid namespace
4303 a("Panax ginseng") -> bp(GOBP:"antioxidant activity") [pos:2] "Panax ginseng" should be qualified with a valid namespace
4304 a("Panax ginseng") -> bp("gastroprotective effects") [pos:2] "Panax ginseng" should be qualified with a valid namespace
4305 a("Panax ginseng") -- bp(MESHPPP:"Gastrointestinal Motility") [pos:2] "Panax ginseng" should be qualified with a valid namespace
4313 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4322 a("Panitumumab") =| p(HGNC:EGFR) [pos:2] "Panitumumab" should be qualified with a valid namespace
4323 composite(a("Panitumumab"),a("FOLFOXIRI")) -> path(MESHD:"Diarrhea") [pos:12] "Panitumumab" should be qualified with a valid namespace
4324 composite(a("Panitumumab"),a("FOLFOXIRI")) -> path("rash") [pos:12] "Panitumumab" should be qualified with a valid namespace
4330 composite(a("Panitumumab"),a("FOLFOXIRI"),p(HGNC:KRAS)) -| bp("survival rate") [pos:12] "Panitumumab" should be qualified with a valid namespace
4331 composite(a("Panitumumab"),a("FOLFOXIRI"),p(HGNC:KRAS)) -| bp("survival rate") [pos:12] "Panitumumab" should be qualified with a valid namespace
4348 a("bevacizumab") -| bp(GOBP:"Angiogenesis") [pos:2] "bevacizumab" should be qualified with a valid namespace
4349 a("bevacizumab") =| p(HGNC:VEGFA) [pos:2] "bevacizumab" should be qualified with a valid namespace
4350 a("aflibercept") -| bp(GOBP:"Angiogenesis") [pos:2] "aflibercept" should be qualified with a valid namespace
4351 a("aflibercept") =| p(HGNC:VEGFA) [pos:2] "aflibercept" should be qualified with a valid namespace
4352 a("ramucirumab") -| bp(GOBP:"Angiogenesis") [pos:2] "ramucirumab" should be qualified with a valid namespace
4353 a("ramucirumab") =| p(HGNC:KDR) [pos:2] "ramucirumab" should be qualified with a valid namespace
4367 SET Trial = "SIRFLOX" "Trial" is not defined
4369 composite(a("selective internal radiation therapy"), a("FOLFOX")) causesNoChange bp("survival rate") [pos:12] "selective internal radiation therapy" should be qualified with a valid namespace
4370 composite(a("selective internal radiation therapy"), a("FOLFOX")) -| path(MESHD:"Disease Progression") [pos:12] "selective internal radiation therapy" should be qualified with a valid namespace
4384 a(CHEBI:"yttrium atom") -> bp("survival rate") [pos:30] "survival rate" should be qualified with a valid namespace
4385 composite(a(CHEBI:"yttrium atom"),a("chemotherapy")) -> bp("survival rate") [pos:36] "chemotherapy" should be qualified with a valid namespace
4397 a("Cetuximab") -> bp("survival rate") [pos:2] "Cetuximab" should be qualified with a valid namespace
4398 a("Bevacizumab") -> bp("survival rate") [pos:2] "Bevacizumab" should be qualified with a valid namespace
4399 a("Panitumumab") -> bp("survival rate") [pos:2] "Panitumumab" should be qualified with a valid namespace
4400 a("Panitumumab") =| p(HGNC:EGFR) [pos:2] "Panitumumab" should be qualified with a valid namespace
4423 composite(a("Ramucirumab"),a("Chemotherapy")) -| bp(GOBP:"angiogenesis") [pos:12] "Ramucirumab" should be qualified with a valid namespace
4424 composite(a("Ramucirumab"),a("Chemotherapy")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "Ramucirumab" should be qualified with a valid namespace
4432 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4437 a(CETIRI) hasMember list(a("Cetuximab"), a(CHEBI:"irinotecan")) [pos:2] "CETIRI" should be qualified with a valid namespace
4438 a(CHEBI:"LSM-1131") -| a("MET Pathway") "LSM-1131" is not in the CHEBI namespace
4439 a("MET pathway") -> bp("anti-EGFR therapy resistance") [pos:2] "MET pathway" should be qualified with a valid namespace
4445 a(CHEBI:"LSM-1131") -> path(MESHD:"Neutropenia") "LSM-1131" is not in the CHEBI namespace
4446 a(CHEBI:"LSM-1131") -> path(MESHD:"Diarrhea") "LSM-1131" is not in the CHEBI namespace
4447 a(CHEBI:"LSM-1131") -> path(MESHD:"Nausea") "LSM-1131" is not in the CHEBI namespace
4448 a(CHEBI:"LSM-1131") -> path("Rash") "LSM-1131" is not in the CHEBI namespace
4461 a("Chemotherapy") -> path(MESHD:"Malnutrition") [pos:2] "Chemotherapy" should be qualified with a valid namespace
4463 path(MESHD:"Malnutrition") -> path("Oncological outcomes") [pos:35] "Oncological outcomes" should be qualified with a valid namespace
4471 path(MESHD:"Malnutrition") -- a("treatment tolerability") [pos:32] "treatment tolerability" should be qualified with a valid namespace
4472 path(MESHD:"Malnutrition") -- path("Anastomotic Leakage") [pos:35] "Anastomotic Leakage" should be qualified with a valid namespace
4473 path(MESHD:"Malnutrition") -- bp("survival rate") [pos:33] "survival rate" should be qualified with a valid namespace
4492 a("biological therapy") -> bp("survival rate") [pos:2] "biological therapy" should be qualified with a valid namespace
4493 a("Bevacizumab") -> bp("survival rate") [pos:2] "Bevacizumab" should be qualified with a valid namespace
4505 a("Cetuximab") -> bp("survival rate") [pos:2] "Cetuximab" should be qualified with a valid namespace
4514 SET DiseaseType = "wild-type KRAS" "wild-type KRAS" is not defined in the DiseaseType annotation
4516 a("Cetuximab") -> bp("survival rate") [pos:2] "Cetuximab" should be qualified with a valid namespace
4518 SET DiseaseType = "mutated KRAS" "mutated KRAS" is not defined in the DiseaseType annotation
4520 a("Cetuximab") causesNoChange bp("survival rate") [pos:2] "Cetuximab" should be qualified with a valid namespace
4527 a("Early Tumor Shrinkage") biomarkerFor a("Cetuximab efficacy") [pos:2] "Early Tumor Shrinkage" should be qualified with a valid namespace
4538 composite(a("FOLFOXIRI"),a("bevacizumab")) -> bp("survival rate") [pos:12] "FOLFOXIRI" should be qualified with a valid namespace
4550 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4555 a("panitumumab") =| p(HGNC:EGFR) [pos:2] "panitumumab" should be qualified with a valid namespace
4556 a("cetuximab") =| p(HGNC:EGFR) [pos:2] "cetuximab" should be qualified with a valid namespace
4557 g(HGNC:KRAS) biomarkerFor bp("panitumumab lack of response") [pos:29] "panitumumab lack of response" should be qualified with a valid namespace
4558 g(HGNC:KRAS) biomarkerFor bp("cetuximab lack of response") [pos:29] "cetuximab lack of response" should be qualified with a valid namespace
4566 a(RAS) hasMembers list(g(HGNC:KRAS),g(HGNC:NRAS)) [pos:2] "RAS" should be qualified with a valid namespace
4567 g(HGNC:KRAS) biomarkerFor bp("survival rate") [pos:29] "survival rate" should be qualified with a valid namespace
4568 g(HGNC:NRAS) biomarkerFor bp("survival rate") [pos:29] "survival rate" should be qualified with a valid namespace
4580 a("(99m)Tc-duramycin") positiveCorrelation bp(GOBP:"cell death") [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4581 a("(99m)Tc-duramycin") positiveCorrelation p(HGNC:ANXA5) [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4582 a("(99m)Tc-duramycin") positiveCorrelation p(HGNC:CASP3) [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4583 a("(99m)Tc-duramycin") positiveCorrelation p(HGNC:CASP7) [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4589 a("(99m)Tc-duramycin") positiveCorrelation a(CHEBI:"irinotecan") [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4597 a("(99m)Tc-duramycin") positiveCorrelation a("Radiotherapy") [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4598 a("(99m)Tc-duramycin") positiveCorrelation deg(p(HGNC:CASP3)) [pos:2] "(99m)Tc-duramycin" should be qualified with a valid namespace
4614 g(HGNC:ABCA9) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4616 g(HGNC:ABCB11) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4618 g(HGNC:ABCC10) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4620 g(HGNC:ATP1A1) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4622 g(HGNC:ATP1B2) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4624 g(HGNC:ATP8B3) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4626 g(HGNC:GSTM5) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4628 g(HGNC:GRHPR) biomarkerFor bp("Oxaliplatin treatment") [pos:31] "Oxaliplatin treatment" should be qualified with a valid namespace
4640 composite(g(HGNC:UGT1A1, var(28)),a(CHEBI:"irinotecan")) -> path(MESHD:"Neutropenia") "irinotecan" is not in the CHEBI namespace
4641 composite(g(HGNC:UGT1A1, var(6)),a(CHEBI:"irinotecan")) -> path(MESHD:"Neutropenia") "irinotecan" is not in the CHEBI namespace
4654 composite(a(CHEBI:"lenalidomide"),a("FOLFOX")) -| path(MESHD:"Colorectal Neoplasms") [pos:36] "FOLFOX" should be qualified with a valid namespace
4660 composite(a(CHEBI:"lenalidomide"),a("FOLFOX")) -> path(MESHD:"Neutropenia") [pos:36] "FOLFOX" should be qualified with a valid namespace
4661 composite(a(CHEBI:"lenalidomide"),a("FOLFOX")) -> path(MESHD:"Thrombocytopenia") [pos:36] "FOLFOX" should be qualified with a valid namespace
4662 composite(a(CHEBI:"lenalidomide"),a("FOLFOX")) -> path(MESHD:"Fatigue") [pos:36] "FOLFOX" should be qualified with a valid namespace
4673 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
4674 a("Cetuximab") -> bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") [pos:2] "Cetuximab" should be qualified with a valid namespace
4679 a("Fcγ receptors") hasMembers list(p(HGNC:FCGBP),p(HGNC:FCGR1A),p(HGNC:FCGR1B),g(HGNC:FCGR1CP),p(HGNC:FCGR2A),p(HGNC:FCGR2B),p(HGNC:FCGR2C),p(HGNC:FCGR3A),p(HGNC:FCGR3B),p(HGNC:FCGRT)) [pos:2] "Fcγ receptors" should be qualified with a valid namespace
4683 g(HGNC:FCGR1CP) -- bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") "FCGR1CP" is not in the HGNC namespace
4700 p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") General Parser Failure on line 4700 at pos 13: p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity")
4701 p(HGNC:FCGR3A, pmod(V,F,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity") General Parser Failure on line 4701 at pos 13: p(HGNC:FCGR3A, pmod(V,F,158)) positiveCorrelation bp(MESHPP:"Antibody-Dependent Cell Cytotoxicity")
4707 p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp("survival rate") General Parser Failure on line 4707 at pos 13: p(HGNC:FCGR3A, pmod(V,V,158)) positiveCorrelation bp("survival rate")
4712 a("Fcγ receptors") biomarkerFor a("Cetuximab Response") [pos:2] "Fcγ receptors" should be qualified with a valid namespace
4724 a("Bevacizumab") =| p(HGNC:VEGFA) [pos:2] "Bevacizumab" should be qualified with a valid namespace
4725 a("Bevacizumab") causesNoChange path(DO:"hemangioma of liver") [pos:2] "Bevacizumab" should be qualified with a valid namespace
4734 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4741 a("FOLFIRI") hasMembers list(a(CHEBI:"Calcium folinate"), a(CHEBI:"5-fluorouracil"), a(CHEBI:"irinotecan")) [pos:2] "FOLFIRI" should be qualified with a valid namespace
4742 a("FUPEP") hasMembers list(a(CHEBI:"Calcium folinate"), a(CHEBI:"5-fluorouracil"), a("PEP02")) [pos:2] "FUPEP" should be qualified with a valid namespace
4748 a("FUPEP") -- path(MESHD:"Diarrhea") [pos:2] "FUPEP" should be qualified with a valid namespace
4749 a("FUPEP") -- path(MESHD:"Neutropenia") [pos:2] "FUPEP" should be qualified with a valid namespace
4750 a("FUPEP") -- path(MESHD:"Mucositis") [pos:2] "FUPEP" should be qualified with a valid namespace
4751 a("FUPEP") -- path(MESHD:"Alopecia") [pos:2] "FUPEP" should be qualified with a valid namespace
4752 a("FOLFIRI") -- path(MESHD:"Diarrhea") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4753 a("FOLFIRI") -- path(MESHD:"Neutropenia") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4754 a("FOLFIRI") -- path(MESHD:"Mucositis") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4755 a("FOLFIRI") -- path(MESHD:"Alopecia") [pos:2] "FOLFIRI" should be qualified with a valid namespace
4778 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4783 composite(a("necitumumab"),a("FOLFOX")) -- path(MESHD:"Neutropenia") [pos:12] "necitumumab" should be qualified with a valid namespace
4784 composite(a("necitumumab"),a("FOLFOX")) -- path(MESHD:"Asthenia") [pos:12] "necitumumab" should be qualified with a valid namespace
4785 composite(a("necitumumab"),a("FOLFOX")) -- path("Rash") [pos:12] "necitumumab" should be qualified with a valid namespace
4790 a("necitumumab") =| p(HGNC:EGFR) [pos:2] "necitumumab" should be qualified with a valid namespace
4791 composite(a("necitumumab"),a("FOLFOX")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "necitumumab" should be qualified with a valid namespace
4792 composite(a("necitumumab"),a("FOLFOX")) -> bp("survival rate") [pos:12] "necitumumab" should be qualified with a valid namespace
4800 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4806 a("Bevacizumab") =| p(HGNC:VEGFA) [pos:2] "Bevacizumab" should be qualified with a valid namespace
4807 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
4808 a("Panitumumab") =| p(HGNC:EGFR) [pos:2] "Panitumumab" should be qualified with a valid namespace
4814 composite(a("Bevacizumab"),a("Cetuximab")) causesNoChange path(MESHD:"Colorectal Neoplasms") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4815 composite(a("Bevacizumab"),a("Panitumumab")) causesNoChange path(MESHD:"Colorectal Neoplasms") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4823 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
4830 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
4836 composite(a("Cetuximab"),a(CHEBI:"oxaliplatin")) -| p(HGNC:CASP3) [pos:12] "Cetuximab" should be qualified with a valid namespace
4837 composite(a("Cetuximab"),a(CHEBI:"oxaliplatin")) -| p(HGNC:CASP7) [pos:12] "Cetuximab" should be qualified with a valid namespace
4841 a(CHEBI:"oxaliplatin") -> a("reactive oxigen species") [pos:28] "reactive oxigen species" should be qualified with a valid namespace
4843 a(CHEBI:"oxaliplatin") -> bp("ROS dependent apoptotsis") [pos:29] "ROS dependent apoptotsis" should be qualified with a valid namespace
4844 a(CHEBI:"SN-38") -> a("reactive oxigen species") [pos:22] "reactive oxigen species" should be qualified with a valid namespace
4853 a("Cetuximab") -| p(HGNC:DUOX2) [pos:2] "Cetuximab" should be qualified with a valid namespace
4854 p(HGNC:DUOX2) -| bp("oxaliplatin cytotoxicity") [pos:20] "oxaliplatin cytotoxicity" should be qualified with a valid namespace
4855 a("Cetuximab") -> p(HGNC:MAPK14) [pos:2] "Cetuximab" should be qualified with a valid namespace
4856 p(HGNC:MAPK14) -| bp("oxaliplatin cytotoxicity") [pos:21] "oxaliplatin cytotoxicity" should be qualified with a valid namespace
4862 a("Cetuximab") -| p(HGNC:STAT1) [pos:2] "Cetuximab" should be qualified with a valid namespace
4863 a("Cetuximab") -| (p(HGNC:DUOX2) -> bp("ROS generation")) [pos:2] "Cetuximab" should be qualified with a valid namespace
4864 a("Cetuximab") -| (p(HGNC:MAPK14) -> bp(GOBP:"apoptotic process")) [pos:2] "Cetuximab" should be qualified with a valid namespace
4865 a("Cetuximab") -| a(CHEBI"oxaliplatin") [pos:2] "Cetuximab" should be qualified with a valid namespace
4890 a("Neoadjuvant concurrent chemoradiotherapy") -> path(MESHD:"Neutropenia") [pos:2] "Neoadjuvant concurrent chemoradiotherapy" should be qualified with a valid namespace
4905 a("irinotecan resistance") causesNoChange a("DEBIRI") [pos:2] "irinotecan resistance" should be qualified with a valid namespace
4906 a("DEBIRI") -| a("adverse events") [pos:2] "DEBIRI" should be qualified with a valid namespace
4918 a("Adjuvant FOLFOX chemotherapy") -> a("received dose intensity") [pos:2] "Adjuvant FOLFOX chemotherapy" should be qualified with a valid namespace
4926 SET DiseaseType = "mutated KRAS" "mutated KRAS" is not defined in the DiseaseType annotation
4931 p(HGNC:KRAS) biomarkerFor bp("therapy resistance") [pos:29] "therapy resistance" should be qualified with a valid namespace
4936 bp(GOBP:"regulation of Ras protein signal transduction") -> bp("cell growth") [pos:63] "cell growth" should be qualified with a valid namespace
4937 bp(GOBP:"MAPK cascade") -> bp("cell growth") [pos:30] "cell growth" should be qualified with a valid namespace
4942 composite(a(CHEBI:"selumetinib"),a("Cetuximab")) -> path("Rash") "selumetinib" is not in the CHEBI namespace
4943 composite(a(CHEBI:"selumetinib"),a("Cetuximab")) -> path(MESHD:"Nausea") "selumetinib" is not in the CHEBI namespace
4944 composite(a(CHEBI:"selumetinib"),a("Cetuximab")) -> path(MESHD:"Vomiting") "selumetinib" is not in the CHEBI namespace
4945 composite(a(CHEBI:"selumetinib"),a("Cetuximab")) -> path(MESHD:"Diarrhea") "selumetinib" is not in the CHEBI namespace
4946 composite(a(CHEBI:"selumetinib"),a("Cetuximab")) -> path(MESHD:"Fatigue") "selumetinib" is not in the CHEBI namespace
4967 SET DiseaseType = {"metastatic", "wild-type RAS"} "metastatic" is not defined in the DiseaseType annotation
4969 composite(a("Panitumumab"), a("FOLFOX")) -> bp("survival rate") [pos:12] "Panitumumab" should be qualified with a valid namespace
4981 composite(a("Bevacizumab"), a(CHEBI:"sorafenib")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4988 composite(a("Bevacizumab"), a(CHEBI:"sorafenib"), a("FOLFIRI")) -> a("disease stabilization") [pos:12] "Bevacizumab" should be qualified with a valid namespace
4999 SET DiseaseType = "wild-type KRAS" "wild-type KRAS" is not defined in the DiseaseType annotation
5001 composite(a("liver-specific intensive chemotherapy"),a("surgery")) -> bp("survival rate") [pos:12] "liver-specific intensive chemotherapy" should be qualified with a valid namespace
5022 composite(a("FOLFOX"), a("bevacizumab")) -| path(MESHD:"Colorectal Neoplasm") [pos:12] "FOLFOX" should be qualified with a valid namespace
5035 composite(a("FOLFIRI"),a("CT guided (125)I-seed implantation")) -> bp("survival rate") [pos:12] "FOLFIRI" should be qualified with a valid namespace
5051 a("early post operative chemotherapy") causesNoChange bp("survival rate") [pos:2] "early post operative chemotherapy" should be qualified with a valid namespace
5059 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
5065 composite(a("Bevacizumab"),a(CHEBI:"capecitabine")) -> path(MESHD:"Hand-Foot Syndrome") [pos:12] "Bevacizumab" should be qualified with a valid namespace
5071 composite(a("Bevacizumab"),a(CHEBI:"capecitabine")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "Bevacizumab" should be qualified with a valid namespace
5082 SET DiseaseType = "wild-type KRAS" "wild-type KRAS" is not defined in the DiseaseType annotation
5084 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
5094 a("Cetuximab") causesNoChange bp(GOBP:"cell growth") [pos:2] "Cetuximab" should be qualified with a valid namespace
5099 a("Cetuximab") causesNoChange bp(GOBP:"cell growth") [pos:2] "Cetuximab" should be qualified with a valid namespace
5105 composite(a(CHEBI:"zoledronic acid"),a("Cetuximab")) =| bp(GOBP:"MAPK cascade") [pos:39] "Cetuximab" should be qualified with a valid namespace
5106 composite(a(CHEBI:"zoledronic acid"),a("Cetuximab")) =| bp(GOBP:"protein kinase B signaling") [pos:39] "Cetuximab" should be qualified with a valid namespace
5129 composite(a(CHEBI:"zoledronic acid"),a("Cetuximab")) =| path(MESHD:"Colorectal Neoplasms") [pos:39] "Cetuximab" should be qualified with a valid namespace
5130 composite(a(CHEBI:"zoledronic acid"),a("Cetuximab")) =| bp(GOBP:"cell growth") [pos:39] "Cetuximab" should be qualified with a valid namespace
5138 a("Peritoneal metastases") -| bp("survival rate") [pos:2] "Peritoneal metastases" should be qualified with a valid namespace
5147 a(CHEBI:"camptothecin") -> bp("survival rate") [pos:30] "survival rate" should be qualified with a valid namespace
5148 a(CHEBI:"oxaliplatin") -> bp("survival rate") [pos:29] "survival rate" should be qualified with a valid namespace
5162 a("XELOX") hasMembers list(a(CHEBI:"capecitabine"), a(CHEBI:"oxaliplatin")) [pos:2] "XELOX" should be qualified with a valid namespace
5169 composite(a("bevacizumab"),a("XELOX")) -> bp(GOBP:"transaminase activity") [pos:12] "bevacizumab" should be qualified with a valid namespace
5170 composite(a("bevacizumab"),a("XELOX")) -> path(MESHD:"Neutropenia") [pos:12] "bevacizumab" should be qualified with a valid namespace
5171 composite(a("bevacizumab"),a("XELOX")) -> path(MESHD:"Fatigue") [pos:12] "bevacizumab" should be qualified with a valid namespace
5172 composite(a("bevacizumab"),a("XELOX")) -> path(MESHD:"Anemia") [pos:12] "bevacizumab" should be qualified with a valid namespace
5173 composite(a("bevacizumab"),a("XELOX")) -> path(MESHD:"Neuropathy") [pos:12] "bevacizumab" should be qualified with a valid namespace
5179 composite(a("bevacizumab"),a("XELOX")) -> bp("survival rate") [pos:12] "bevacizumab" should be qualified with a valid namespace
5197 a(CHEBI:"irinotecan") -> path(MESHD:"Neutropenia") "irinotecan" is not in the CHEBI namespace
5198 a(CHEBI:"irinotecan") -> path(MESHD:"Diarrhea") "irinotecan" is not in the CHEBI namespace
5203 bp(MESHPP:"Fasting") -| a(CHEBI:"irinotecan") "irinotecan" is not in the CHEBI namespace
5204 a(CHEBI:"irinotecan") -> path(MESHD:"Diarrhea")) "irinotecan" is not in the CHEBI namespace
5209 a(CHEBI:"irinotecan") positiveCorrelation path(MESHD:"Leukopenia") "irinotecan" is not in the CHEBI namespace
5210 composite(a(CHEBI:"irinotecan"),bp(MESHPP:"Fasting")) negativeCorrelation path(MESHD:"Leukopenia") "irinotecan" is not in the CHEBI namespace
5215 a(CHEBI:"irinotecan") -| bp(GOBP:"cell growth") "irinotecan" is not in the CHEBI namespace
5216 a(CHEBI:"irinotecan") -| path(MESHD:"Colorectal Neoplasms") "irinotecan" is not in the CHEBI namespace
5224 composite(a(CHEBI:"irinotecan"),bp(MESHPP:"Fasting")) negativeCorrelation a(CHEBI:"SN-38") "irinotecan" is not in the CHEBI namespace
5228 composite(a(CHEBI:"irinotecan"),bp(MESHPP:"Fasting")) negativeCorrelation a(CHEBI:"SN-38") "irinotecan" is not in the CHEBI namespace
5230 SET UserdefinedCell = "Tumor" "Tumor" is not defined in the UserdefinedCell annotation
5232 composite(a(CHEBI:"irinotecan"),bp(MESHPP:"Fasting")) positiveCorrelation a(CHEBI:"SN-38") "irinotecan" is not in the CHEBI namespace
5237 bp(MESHPP:"Fasting") -| a("side effects") [pos:26] "side effects" should be qualified with a valid namespace
5238 bp(MESHPP:"Fasting") causesNoChange a(CHEBI:"irinotecan") "irinotecan" is not in the CHEBI namespace
5239 a(CHEBI:"irinotecan") -| bp(GOBP:"cell growth") "irinotecan" is not in the CHEBI namespace
5250 a("Cetuximab") =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
5251 a("Cetuximab") -> path(MESHD:"Acneiform Eruptions") [pos:2] "Cetuximab" should be qualified with a valid namespace
5262 p(HGNC:KDR) -- bp("survival rate") [pos:18] "survival rate" should be qualified with a valid namespace
5263 p(HGNC:KDR) negativeCorrelation bp("survival rate") [pos:35] "survival rate" should be qualified with a valid namespace
5268 composite(p(HGNC:KDR),a("chemotherapy"),a("bevacizumab")) -> bp("survival rate") [pos:24] "chemotherapy" should be qualified with a valid namespace
5278 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
5283 a("resection of metastases") -> bp("survival rate") [pos:2] "resection of metastases" should be qualified with a valid namespace
5289 composite(a("bevacizumab"),a(CHEBI:"irinotecan")) -> bp("survival rate") [pos:12] "bevacizumab" should be qualified with a valid namespace
5304 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
5306 a("Bevacizumab") -- path(MESHD:"Venous Thromoembolisms") [pos:2] "Bevacizumab" should be qualified with a valid namespace
5314 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
5320 tscript(p(HGNC:AREG)) -- bp("survival rate") [pos:28] "survival rate" should be qualified with a valid namespace
5325 tscript(p(HGNC:EREG)) -- bp("survival rate") [pos:28] "survival rate" should be qualified with a valid namespace
5331 tscript(p(HGNC:EREG)) biomarkerFor bp("survival rate") [pos:38] "survival rate" should be qualified with a valid namespace
5343 SET DiseaseType = "metastatic" "metastatic" is not defined in the DiseaseType annotation
5351 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Neutropenia") [pos:12] "FOLFOX" should be qualified with a valid namespace
5352 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Leukopenia") [pos:12] "FOLFOX" should be qualified with a valid namespace
5353 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Anorexia") [pos:12] "FOLFOX" should be qualified with a valid namespace
5354 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Fatigue") [pos:12] "FOLFOX" should be qualified with a valid namespace
5355 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Nausea") [pos:12] "FOLFOX" should be qualified with a valid namespace
5356 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -- path(MESHD:"Vomiting") [pos:12] "FOLFOX" should be qualified with a valid namespace
5357 a("bevacizumab") -- path(MESHD:"Hypertension") [pos:2] "bevacizumab" should be qualified with a valid namespace
5358 a("bevacizumab") -- path(MESHD:"Thrombosis") [pos:2] "bevacizumab" should be qualified with a valid namespace
5364 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "FOLFOX" should be qualified with a valid namespace
5365 composite(a("FOLFOX"),a("bevacizumab"),a("FOLFIRI")) -| path(MESHD:"Colorectal Neoplasms") [pos:12] "FOLFOX" should be qualified with a valid namespace
5398 p(HGNC:UBE3D) -| a("irinotecan sensitivity") [pos:19] "irinotecan sensitivity" should be qualified with a valid namespace
5399 p(HGNC:UBE3D) -| a("SN-38 sensitivity") [pos:19] "SN-38 sensitivity" should be qualified with a valid namespace
5400 p(HGNC:UBE3D) -| a("cetuximab sensitivity") [pos:19] "cetuximab sensitivity" should be qualified with a valid namespace
5402 p(HGNC:AKT1) -- a("irinotecan sensitivity") [pos:18] "irinotecan sensitivity" should be qualified with a valid namespace
5403 p(HGNC:AKT1) -- a("SN-38 sensitivity") [pos:18] "SN-38 sensitivity" should be qualified with a valid namespace
5404 p(HGNC:AKT1) -- a("cetuximab sensitivity") [pos:18] "cetuximab sensitivity" should be qualified with a valid namespace
5412 p(HGNC:UBE3D) biomarkerFor bp("Chemoresistance") [pos:30] "Chemoresistance" should be qualified with a valid namespace
5449 a("cancer stem cells") -- path(MESHD:"Cell Transformation, Neoplastic") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5450 a("cancer stem cells") -- path(MESHD:"Neoplasm Metastasis") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5471 tscript(p(HGNC:ERBB3)) -- a("survival rate") [pos:28] "survival rate" should be qualified with a valid namespace
5472 p(HGNC:ERBB3) -> a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
5488 a("Mab#58") -- a("HER3/RH7777 cells") [pos:2] "Mab#58" should be qualified with a valid namespace
5498 a("Mab#58") biomarkerFor path(MESHD:"Colorectal Neoplasms") [pos:2] "Mab#58" should be qualified with a valid namespace
5519 a("cancer stem cells") -- bp(GOBP:"cell growth") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5520 a("cancer stem cells") -- path(MESHD:"Neoplasm Metastasis") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5521 a("cancer stem cells") -- bp(GOBP:"cell migration") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5522 a("cancer stem cells") -- path(MESHD:"Cell Transformation, Neoplastic") [pos:2] "cancer stem cells" should be qualified with a valid namespace
5531 a("cancer stem cells") -- p(HGNC:CD44) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5532 a("cancer stem cells") -- p(HGNC:PROM1) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5533 a("cancer stem cells") -- p(HGNC:CD24) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5534 a("cancer stem cells") -- p(HGNC:EPCAM) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5535 a("cancer stem cells") -- p(HGNC:LGR5) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5536 a("cancer stem cells") -- p(HGNC:ALDH1A1) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5537 a("cancer stem cells") -- p(HGNC:BMI1) [pos:2] "cancer stem cells" should be qualified with a valid namespace
5562 p(HGNC:DAPK1) negativeCorrelation a("Tumor buds") [pos:36] "Tumor buds" should be qualified with a valid namespace
5564 p(HGNC:DAPK1) -| a("survival rate") [pos:19] "survival rate" should be qualified with a valid namespace
5613 deg(complex(p(HGNC:ITGB1),p(HGNC:EGFR))) -> a("radiosensitivity") [pos:46] "radiosensitivity" should be qualified with a valid namespace
5614 p(HGNC:ITGB1) -> a("radiosensitivity") [pos:19] "radiosensitivity" should be qualified with a valid namespace
5615 p(HGNC:EGFR) -> a("radiosensitivity") [pos:18] "radiosensitivity" should be qualified with a valid namespace
5619 SET CellLine = {"DLD1","HT-29"} "DLD1" is not defined in the CellLine annotation
5632 a(AIIB2) =| p(HGNC:ITGB1) [pos:2] "AIIB2" should be qualified with a valid namespace
5633 a(TAE226) =| p(HGNC:PTK2) [pos:2] "TAE226" should be qualified with a valid namespace
5634 a(TAE226) =| p(HGNC:PTK2) [pos:2] "TAE226" should be qualified with a valid namespace
5635 a(Cetuximab) =| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
5637 deg(complex(p(HGNC:ITGB1),p(HGNC:EGFR))) causesNoChange a("radiosensitivity") [pos:58] "radiosensitivity" should be qualified with a valid namespace
5638 deg(p(HGNC:BRAF)) causesNoChange a("radiosensitivity") [pos:35] "radiosensitivity" should be qualified with a valid namespace
5639 deg(p(HGNC:KRAS)) causesNoChange a("radiosensitivity") [pos:35] "radiosensitivity" should be qualified with a valid namespace
5640 a(CHEBI:"5-fluorouracil") causesNoChange a("radiosensitivity") [pos:43] "radiosensitivity" should be qualified with a valid namespace
5642 complex(a(Cetuximab),a(AIIB2)) -- bp(MESHPP:"MAP Kinase Signaling System") [pos:10] "Cetuximab" should be qualified with a valid namespace
5643 complex(a(Cetuximab),a(AIIB2)) -- kin(p(HGNC:MAPK8)) [pos:10] "Cetuximab" should be qualified with a valid namespace
5644 complex(a(Cetuximab),a(AIIB2)) -- kin(p(HGNC:AKT1)) [pos:10] "Cetuximab" should be qualified with a valid namespace
5645 a(Cetuximab) -- bp(MESHPP:"MAP Kinase Signaling System") [pos:2] "Cetuximab" should be qualified with a valid namespace
5646 a(Cetuximab) -- kin(p(HGNC:MAPK8)) [pos:2] "Cetuximab" should be qualified with a valid namespace
5647 a(Cetuximab) -- kin(p(HGNC:AKT1)) [pos:2] "Cetuximab" should be qualified with a valid namespace
5648 a(AIIB2) -- bp(MESHPP:"MAP Kinase Signaling System") [pos:2] "AIIB2" should be qualified with a valid namespace
5649 a(AIIB2) -- kin(p(HGNC:MAPK8)) [pos:2] "AIIB2" should be qualified with a valid namespace
5650 a(AIIB2) -- kin(p(HGNC:AKT1)) [pos:2] "AIIB2" should be qualified with a valid namespace
5658 a(AIIB2) -| path(MESHD:"Neoplasm Invasiveness") [pos:2] "AIIB2" should be qualified with a valid namespace
5659 a(TAE226) -| path(MESHD:"Neoplasm Invasiveness") [pos:2] "TAE226" should be qualified with a valid namespace
5660 a(TAE226) -| path(MESHD:"Neoplasm Invasiveness") [pos:2] "TAE226" should be qualified with a valid namespace
5675 deg(p(HGNC:HGF)) -| bp("Chemoresistance") [pos:23] "Chemoresistance" should be qualified with a valid namespace
5681 complex(a("anti-HGF"),a(CHEBI:"Irinotecan")) => a("Irinotecan sensitivity") [pos:10] "anti-HGF" should be qualified with a valid namespace
5696 complex(a(anti-HGF),a(CHEBI:"Irinotecan")) =| bp(GOBP:"cell growth") [pos:10] "anti" should be qualified with a valid namespace
5698 p(HGNC:HGF) biomarkerFor bp("Chemoresistance") [pos:28] "Chemoresistance" should be qualified with a valid namespace
5699 p(HGNC:HGF) -> bp("Chemoresistance") [pos:18] "Chemoresistance" should be qualified with a valid namespace
5700 p(HGNC:HGF) -| a("Irinotecan sensitivity") [pos:17] "Irinotecan sensitivity" should be qualified with a valid namespace
5701 a("anti-HGF") -| p(HGNC:HGF) [pos:2] "anti-HGF" should be qualified with a valid namespace
5702 a("anti-HGF") -| bp("Chemoresistance") [pos:2] "anti-HGF" should be qualified with a valid namespace
5731 p(HGNC:KRAS) -> a("anti-EGFR resistance") [pos:18] "anti-EGFR resistance" should be qualified with a valid namespace
5732 p(HGNC:NRAS) -> a("anti-EGFR resistance") [pos:18] "anti-EGFR resistance" should be qualified with a valid namespace
5740 p(HGNC:KRAS) -- a("Cetuximab resistance") [pos:18] "Cetuximab resistance" should be qualified with a valid namespace
5741 p(HGNC:KRAS) -- a("panitumumab resistance") [pos:18] "panitumumab resistance" should be qualified with a valid namespace
5742 p(HGNC:PIK3CA) -- a("Cetuximab resistance") [pos:20] "Cetuximab resistance" should be qualified with a valid namespace
5743 p(HGNC:PIK3CA) -- a("panitumumab resistance") [pos:20] "panitumumab resistance" should be qualified with a valid namespace
5744 p(HGNC:BRAF) -- a("Cetuximab resistance") [pos:18] "Cetuximab resistance" should be qualified with a valid namespace
5745 p(HGNC:BRAF) -- a("panitumumab resistance") [pos:18] "panitumumab resistance" should be qualified with a valid namespace
5746 p(HGNC:ERBB2) -- a("Cetuximab resistance") [pos:19] "Cetuximab resistance" should be qualified with a valid namespace
5747 p(HGNC:ERBB2) -- a("panitumumab resistance") [pos:19] "panitumumab resistance" should be qualified with a valid namespace
5748 p(HGNC:MET) -- a("Cetuximab resistance") [pos:17] "Cetuximab resistance" should be qualified with a valid namespace
5749 p(HGNC:MET) -- a("panitumumab resistance") [pos:17] "panitumumab resistance" should be qualified with a valid namespace
5758 p(HGNC:ERBB3) -> a("anti-EGFR resistance") [pos:19] "anti-EGFR resistance" should be qualified with a valid namespace
5759 p(HGNC:MET) -> a("anti-EGFR resistance") [pos:17] "anti-EGFR resistance" should be qualified with a valid namespace
5760 p(HGNC:TGFA) -> a("anti-EGFR resistance") [pos:18] "anti-EGFR resistance" should be qualified with a valid namespace
5761 p(HGNC:HGF) -> a("anti-EGFR resistance") [pos:17] "anti-EGFR resistance" should be qualified with a valid namespace
5779 a("miRNA-497") biomarkerFor a("neoadjuvant sensitivity") [pos:2] "miRNA-497" should be qualified with a valid namespace
5780 a("miRNA-497") -| p(HGNC:SMURF1) [pos:2] "miRNA-497" should be qualified with a valid namespace
5781 p(HGNC:SMURF1) positiveCorrelation a("5-fluorouracil resistance") [pos:37] "5-fluorouracil resistance" should be qualified with a valid namespace
5782 a("miRNA-497") negativeCorrelation a("neoadjuvant") [pos:2] "miRNA-497" should be qualified with a valid namespace
5783 deg(a("miRNA-497")) -> a("5-fluorouracil resistance") [pos:6] "miRNA-497" should be qualified with a valid namespace
5784 deg(a("miRNA-497")) -> a("neoadjuvant") [pos:6] "miRNA-497" should be qualified with a valid namespace
5793 a("miRNA-497") -- a(CHEBI:"5-fluorouracil") [pos:2] "miRNA-497" should be qualified with a valid namespace
5794 a("miRNA-497") -| a("5-fluorouracil resistance") [pos:2] "miRNA-497" should be qualified with a valid namespace
5795 a("miRNA-497") -| a("chemoresistance") [pos:2] "miRNA-497" should be qualified with a valid namespace
5803 SET CellLine = "LoVo" "LoVo" is not defined in the CellLine annotation
5805 deg(a("miRNA-497")) -> bp(GOBP:"cell growth") [pos:6] "miRNA-497" should be qualified with a valid namespace
5806 deg(a("miRNA-497")) -> a("5-fluorouracil resistance") [pos:6] "miRNA-497" should be qualified with a valid namespace
5822 path(MESHD:"Rectal Neoplasms") positiveCorrelation bp("Chemoresistance") [pos:54] "Chemoresistance" should be qualified with a valid namespace
5832 kin(p(HGNC:PIK3CA)) positiveCorrelation bp("Chemoresistance") [pos:43] "Chemoresistance" should be qualified with a valid namespace
5833 kin(p(HGNC:PIK3CA)) positiveCorrelation a("neoadjuvant resistance") [pos:42] "neoadjuvant resistance" should be qualified with a valid namespace
5847 p(HGNC:IL17A) -> a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
5876 a("therapy resistance") -| bp(GOBP:"apoptotic process") [pos:2] "therapy resistance" should be qualified with a valid namespace
5884 p(HGNC:BCL2L1) causesNoChange a("survival rate") [pos:32] "survival rate" should be qualified with a valid namespace
5885 p(HGNC:MCL1) causesNoChange a("survival rate") [pos:30] "survival rate" should be qualified with a valid namespace
5886 p(HGNC:BCL2) -- a("survival rate") [pos:18] "survival rate" should be qualified with a valid namespace
5887 deg(p(HGNC:BCL2)) -> a("survival rate") [pos:23] "survival rate" should be qualified with a valid namespace
5897 p(GFAM:"BCL2 family") biomarkerFor path(MESHD:"Rectal Neoplasms") "GFAM" is not a defined namespace
5911 p(HGNC:BRAF) -- a("therapy resistance") [pos:18] "therapy resistance" should be qualified with a valid namespace
5969 kin(p(HGNC:AKT1,pmod(P,S,473))) -- a("therapy resistance") [pos:37] "therapy resistance" should be qualified with a valid namespace
6029 a("hypoxia") -> a("therapy resistance") [pos:2] "hypoxia" should be qualified with a valid namespace
6076 a("tumor microenvironment") -- a("therapy resistance") [pos:2] "tumor microenvironment" should be qualified with a valid namespace
6077 a("tumor microenvironment") -- path(MESHD:"Neoplasm Invasiveness") [pos:2] "tumor microenvironment" should be qualified with a valid namespace
6078 a("tumor microenvironment") -- path(MESHD:"Neoplasm Metastasis") [pos:2] "tumor microenvironment" should be qualified with a valid namespace
6082 SET Citation = {"PubMed","Anticancer Res. 2014 Feb;34(2):845-50.",""} [pos:4] "" is not a valid PubMed identifier
6091 a(CHEBI:"capecitabine") -> a("Survival Rate") [pos:29] "Survival Rate" should be qualified with a valid namespace
6092 a(CHEBI:"gemcitabine") -> a("Survival Rate") [pos:28] "Survival Rate" should be qualified with a valid namespace
6109 p(HGNC:KRAS) -- bp("anti-EGFR therapy resistance") [pos:19] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6110 p(HGNC:BRAF) -- bp("anti-EGFR therapy resistance") [pos:19] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6111 p(HGNC:NRAS) -- bp("anti-EGFR therapy resistance") [pos:19] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6112 p(HGNC:PIK3CA) -- bp("anti-EGFR therapy resistance") [pos:21] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6113 p(HGNC:ERCC1) -- bp("therapy resistance") [pos:20] "therapy resistance" should be qualified with a valid namespace
6114 p(HGNC:MET) -- bp("therapy resistance") [pos:18] "therapy resistance" should be qualified with a valid namespace
6115 p(HGNC:PTEN) -- bp("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6116 p(HGNC:ERBB2) -- bp("therapy resistance") [pos:20] "therapy resistance" should be qualified with a valid namespace
6117 p(HGNC:ERBB3) -- bp("therapy resistance") [pos:20] "therapy resistance" should be qualified with a valid namespace
6124 p(HGNC:KRAS) biomarkerFor bp("anti-EGFR therapy resistance") [pos:29] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6125 p(HGNC:BRAF) biomarkerFor bp("anti-EGFR therapy resistance") [pos:29] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6126 p(HGNC:NRAS) biomarkerFor bp("anti-EGFR therapy resistance") [pos:29] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6127 p(HGNC:PIK3CA) biomarkerFor bp("anti-EGFR therapy resistance") [pos:31] "anti-EGFR therapy resistance" should be qualified with a valid namespace
6128 p(HGNC:ERCC1) biomarkerFor bp("therapy resistance") [pos:30] "therapy resistance" should be qualified with a valid namespace
6129 p(HGNC:MET) biomarkerFor bp("therapy resistance") [pos:28] "therapy resistance" should be qualified with a valid namespace
6130 p(HGNC:PTEN) biomarkerFor bp("therapy resistance") [pos:29] "therapy resistance" should be qualified with a valid namespace
6131 p(HGNC:ERBB2) biomarkerFor bp("therapy resistance") [pos:30] "therapy resistance" should be qualified with a valid namespace
6132 p(HGNC:ERBB3) biomarkerFor bp("therapy resistance") [pos:30] "therapy resistance" should be qualified with a valid namespace
6171 a(GSH-PX) hasMember list(p(HGNC:GPX1),p(HGNC:GPX2),p(HGNC:GPX3),p(HGNC:GPX4),p(HGNC:GPX6)) [pos:2] "GSH" should be qualified with a valid namespace
6172 a(CHEBI:"Salinomycin") -| a(GSH-PX) [pos:28] "GSH" should be qualified with a valid namespace
6216 a(CHEBI:"oxaliplatin") -> a("DNA cross-links") [pos:28] "DNA cross-links" should be qualified with a valid namespace
6217 a(CHEBI:"oxaliplatin") -> a("chemoresistance") [pos:28] "chemoresistance" should be qualified with a valid namespace
6240 m("miR-27b") negativeCorrelation path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-27b" should be qualified with a valid namespace
6241 m("miR-27b") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "miR-27b" should be qualified with a valid namespace
6242 m("miR-27b") -| bp(GOBP:"cell growth") [pos:2] "miR-27b" should be qualified with a valid namespace
6243 m("miR-27b") -| p(HGNC:VEGFC) [pos:2] "miR-27b" should be qualified with a valid namespace
6244 m("miR-27b") -| bp(GOBP:"angiogenesis") [pos:2] "miR-27b" should be qualified with a valid namespace
6245 g("miR-27b",) -| tscript(m("miR-27b")) #MI: I don't see how to express something as CpG islands [pos:2] "miR-27b" should be qualified with a valid namespace
6246 m("miR-27b") -> bp(MESHPP:Necrosis) [pos:2] "miR-27b" should be qualified with a valid namespace
6296 p(HGNC:SLC29A1) positiveCorrelation a("5-fluorouracil resistance") [pos:38] "5-fluorouracil resistance" should be qualified with a valid namespace
6297 deg(p(HGNC:SLC29A1)) -| a("5-fluorouracil resistance") [pos:26] "5-fluorouracil resistance" should be qualified with a valid namespace
6314 p(HGNC:RAD51) negativeCorrelation a("survival rate") [pos:36] "survival rate" should be qualified with a valid namespace
6328 a(MLH) hasMember list(p(HGNC:MLH1),p(HGNC:PMS1),p(HGNC:MLH3),p(HGNC:PMS2)) [pos:2] "MLH" should be qualified with a valid namespace
6329 p(HGNC:RAD51) negativeCorrelation a(MHL) [pos:36] "MHL" should be qualified with a valid namespace
6348 p(HGNC:GSN) negativeCorrelation a("survival rate") [pos:34] "survival rate" should be qualified with a valid namespace
6349 p(HGNC:GSN) positiveCorrelation a("therapy resistance") [pos:34] "therapy resistance" should be qualified with a valid namespace
6403 p(HGNC:BIRC5) -> a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6413 m("survivin-miRNA") =| p(HGNC:BIRC5) [pos:2] "survivin-miRNA" should be qualified with a valid namespace
6414 m("survivin-miRNA") -| a("therapy resistance") [pos:2] "survivin-miRNA" should be qualified with a valid namespace
6484 a("cancer stem cells") -> bp(GOBP:"cell growth") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6501 a("cancer stem cells") -- path(MESHD:"Cell Transformation, Neoplastic") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6502 a("cancer stem cells") -- bp(GOBP:"cell growth") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6503 p(HGNC:PROM1) -- a("cancer stem cells") [pos:19] "cancer stem cells" should be qualified with a valid namespace
6504 p(HGNC:CD44) -- a("cancer stem cells") [pos:18] "cancer stem cells" should be qualified with a valid namespace
6505 p(HGNC:CD24) -- a("cancer stem cells") [pos:18] "cancer stem cells" should be qualified with a valid namespace
6506 p(HGNC:ITGB1) -- a("cancer stem cells") [pos:19] "cancer stem cells" should be qualified with a valid namespace
6507 p(HGNC:ALCAM) -- a("cancer stem cells") [pos:19] "cancer stem cells" should be qualified with a valid namespace
6508 p(HGNC:LGR5) -- a("cancer stem cells") [pos:18] "cancer stem cells" should be qualified with a valid namespace
6522 a("hypoxia resistance") -- bp(GOBP:"cell growth") [pos:2] "hypoxia resistance" should be qualified with a valid namespace
6523 a("hypoxia resistance") -- a("therapy resistance") [pos:2] "hypoxia resistance" should be qualified with a valid namespace
6524 a("hypoxia resistance") -- p(HGNC:HIF1A) [pos:2] "hypoxia resistance" should be qualified with a valid namespace
6559 p(HGNC:LOX) -> a("hypoxia resistance") [pos:17] "hypoxia resistance" should be qualified with a valid namespace
6560 p(HGNC:HIF1A) -> a("hypoxia resistance") [pos:19] "hypoxia resistance" should be qualified with a valid namespace
6599 a("cancer stem cells") -> a("therapy resistance") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6604 bp(GOBP:"Wnt signaling pathway") -> a("cancer stem cells") [pos:38] "cancer stem cells" should be qualified with a valid namespace
6617 p(HGNC:PROM1) -- a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6623 p(HGNC:PROM1) negativeCorrelation a("survival rate") [pos:36] "survival rate" should be qualified with a valid namespace
6656 p("Cep55/c10orf3_193(10)(VYVKGLLAKI)") => bp(GOBP:"antibody-dependent cellular cytotoxicity") [pos:2] "Cep55/c10orf3_193(10)(VYVKGLLAKI)" should be qualified with a valid namespace
6657 p("anti-Cep55/c10orf3 antibody (# 11-55)") => bp(GOBP:"antibody-dependent cellular cytotoxicity") [pos:2] "anti-Cep55/c10orf3 antibody (# 11-55)" should be qualified with a valid namespace
6674 a("cancer stem cells") -- a("therapy resistance") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6675 a("cancer stem cells") -> path(MESHD:"Neoplasm Metastasis") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6676 a("cancer stem cells") -- a("chemoresistance") [pos:2] "cancer stem cells" should be qualified with a valid namespace
6696 p(HGNC:SPARC) -| a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6727 p(HGNC:SPARC) -| bp("Chemoresistance") [pos:20] "Chemoresistance" should be qualified with a valid namespace
6728 p(HGNC:SPARC) -| a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6745 m("CASP8 small-interfering RNA") -| bp(GOBP:"apoptotic process") [pos:2] "CASP8 small-interfering RNA" should be qualified with a valid namespace
6762 p(HGNC:SPARC) =| bp("Chemoresistance") [pos:20] "Chemoresistance" should be qualified with a valid namespace
6763 g(HGNC:SPARC) =| bp("Chemoresistance") [pos:20] "Chemoresistance" should be qualified with a valid namespace
6765 p(HGNC:SPARC) =| a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6766 g(HGNC:SPARC) =| a("therapy resistance") [pos:19] "therapy resistance" should be qualified with a valid namespace
6785 a(CHEBI:"vitamin D") =| bp("Chemoresistance") [pos:27] "Chemoresistance" should be qualified with a valid namespace
6802 composite(p(HGNC:SPARC),a(CHEBI:"vitamin D")) =| a("therapy resistance") [pos:51] "therapy resistance" should be qualified with a valid namespace
6818 a("limited resection of the colon") -> a("survival rate") [pos:2] "limited resection of the colon" should be qualified with a valid namespace
6835 a("Tumor-infiltrating lymphocytes") biomarkerFor a("solid tumors") [pos:2] "Tumor-infiltrating lymphocytes" should be qualified with a valid namespace
6836 a("regulatory T cells (Treg)") -- bp(GOBP:"cell growth") [pos:2] "regulatory T cells (Treg)" should be qualified with a valid namespace
6837 a("B+ cytotoxic cells") positiveCorrelation bp(GOBP:"cell growth") [pos:2] "B+ cytotoxic cells" should be qualified with a valid namespace
6852 a(Cetuximab) -| p(HGNC:EGFR) [pos:2] "Cetuximab" should be qualified with a valid namespace
6853 composite(a(Cetuximab),a(CHEBI:"irinotecan")) -| p(HGNC:EGFR) [pos:12] "Cetuximab" should be qualified with a valid namespace
6875 composite(a(CHEBI:"dexamethasone"),a("gamma-irradiation")) -| bp(GOBP:"apoptotic process") [pos:37] "gamma-irradiation" should be qualified with a valid namespace
6877 a(CHEBI:"dexamethasone") -> a("therapy resistance") [pos:30] "therapy resistance" should be qualified with a valid namespace
6898 tscript(p(HGNC:SPARC)) -| a("therapy resistance") [pos:28] "therapy resistance" should be qualified with a valid namespace
6900 tscript(p(HGNC:SPARC)) -> a("Irinotecan sensitivity") [pos:28] "Irinotecan sensitivity" should be qualified with a valid namespace
6901 tscript(p(HGNC:SPARC)) -> a("5-fluorouracil sensitivity") [pos:28] "5-fluorouracil sensitivity" should be qualified with a valid namespace
6902 tscript(p(HGNC:SPARC)) -> a("radiosensitivity") [pos:28] "radiosensitivity" should be qualified with a valid namespace
6931 bp(GOBP:"cell adhesion") causesNoChange a("therapy resistance") [pos:42] "therapy resistance" should be qualified with a valid namespace
6932 p(HGNC:ITGB1) causesNoChange a("therapy resistance") [pos:31] "therapy resistance" should be qualified with a valid namespace
6948 p(HGNC:MT1A) -- a("therapy resistance") [pos:18] "therapy resistance" should be qualified with a valid namespace
6959 p(HGNC:MT1A) -| a("survival rate") [pos:18] "survival rate" should be qualified with a valid namespace
6962 p(HGNC:MT1A) biomarkerFor bp("poor survival") [pos:29] "poor survival" should be qualified with a valid namespace
6981 p(HGNC:MT1A) -- a("therapy resistance") [pos:18] "therapy resistance" should be qualified with a valid namespace
7011 a(CHEBI:"5-fluorouracil") -| a("5-fluorouracil resistance") [pos:31] "5-fluorouracil resistance" should be qualified with a valid namespace
7023 composite(p(HGNC:IFNA2), a(CHEBI:"5-fluorouracil")) -> path("Drug Toxicity") [pos:60] "Drug Toxicity" should be qualified with a valid namespace
7031 a(CHEBI:"5-fluorouracil") -> a("5-fluorouracil resistance") [pos:31] "5-fluorouracil resistance" should be qualified with a valid namespace
7046 a("chemotherapy") -- path(MESHD:Necrosis) [pos:2] "chemotherapy" should be qualified with a valid namespace
7062 a("microsatellite instability") -- path(MESHD:"Prostatic Neoplasms") [pos:2] "microsatellite instability" should be qualified with a valid namespace
7063 a("microsatellite instability") -- p(HGNC:AR) [pos:2] "microsatellite instability" should be qualified with a valid namespace
7064 a("microsatellite instability") -| a("survival rate") [pos:2] "microsatellite instability" should be qualified with a valid namespace
7149 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
7150 SET Pathway = "ECM-receptor interaction pathway" "Pathway" is not defined
7157 path(MESHD:"Colorectal Neoplasms") -> (GOCC:"extracellular matrix component") General Parser Failure on line 7157 at pos 40: path(MESHD:"Colorectal Neoplasms") -> (GOCC:"extracellular matrix component")
7163 g(dbSNP:rs12695175) -- g(HGNC:CD47) "dbSNP" is not a defined namespace
7166 UNSET Pathway "Pathway" is not defined
7174 SET Pathway = "ECM-receptor interaction pathway" "Pathway" is not defined
7178 c(GOCC:"ribosome") -- g(HGNC:RPL13) General Parser Failure on line 7178 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL13)
7179 c(GOCC:"ribosome") -- g(HGNC:RPL27A) General Parser Failure on line 7179 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL27A)
7180 c(GOCC:"ribosome") -- g(HGNC:RPL4) General Parser Failure on line 7180 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPL4)
7181 c(GOCC:"ribosome") -- g(HGNC:RPS18) General Parser Failure on line 7181 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPS18)
7182 c(GOCC:"ribosome") -- g(HGNC:RPS29) General Parser Failure on line 7182 at pos 0: c(GOCC:"ribosome") -- g(HGNC:RPS29)
7184 UNSET Pathway "Pathway" is not defined
7190 SET Evidence = {"Curcumin has extensive cardioprotective effects against diabetic cardiovascular complications, cardiac hypertrophy and myocardial infarction (MI), but the molecular mechanism behind such cardioprotective effects remains still unclear. "} SET Species = "10116" "Evidence" is not defined
7193 SET Pathway = "ECM-receptor interaction pathway" "Pathway" is not defined
7198 SET Evidence = {"Cytokine-cytokine receptor interaction, ECM-receptor interaction, focal adhesions and colorectal cancer pathway may be involved in the cardioprotective effects of curcumin."} SET Species = "10116" "Evidence" is not defined
7201 a(CHEBI:"Curcumin diglucoside") -- bp(GO:"cell-matrix adhesion") "GO" is not a defined namespace
7202 a(CHEBI:"Curcumin diglucoside") -- bp(GO:"focal adhesion assembly") "GO" is not a defined namespace
7204 UNSET Pathway "Pathway" is not defined
7210 SET Evidence = {"The aim of the present study was to screen and identify the chromosomal aberrations that are correlated with clinicopathological characteristics of rectal cancer using array-based comparative genomic hybridization (array-CGH)"} SET Pathway = "Cytokine-cytokine receptor interaction" "Evidence" is not defined
7213 path(MESHD:"Colorectal Neoplasms") -- path(MESHD:Chromosome Aberrations) "Chromosome" is not in the MESHD namespace
7215 UNSET Pathway "Pathway" is not defined
7221 SET Evidence = {"Oral squamous cell carcinoma (OSCC) is a common malignancy, in which lymph node metastasis is a major determinant of outcome"} SET Pathway = "Cytokine-cytokine receptor interaction" "Evidence" is not defined
7225 path(MESHD:Chromosome Aberrations) -> path(DO:"lymph node cancer") "Chromosome" is not in the MESHD namespace
7227 UNSET Pathway "Pathway" is not defined
7236 a(HGNC:L1CAM) -- bp(GOBP:"Wnt signaling pathway") Abundance HGNC:L1CAM should be encoded as one of: miRNA, Gene, RNA, Protein
7237 a(HGNC:L1CAM) -- path(MESHD:"Colorectal Neoplasms") Abundance HGNC:L1CAM should be encoded as one of: miRNA, Gene, RNA, Protein
7240 SET Pathway = "Wnt/beta-catenin/tcf signaling pathway" "Pathway" is not defined
7241 surf(g(HGNC:L1CAMN)) -> bp("beta-catenin signaling pathway") "L1CAMN" is not in the HGNC namespace
7244 a(HGNC:L1CAM)-> path(MESHD:"Colorectal Neoplasms") Abundance HGNC:L1CAM should be encoded as one of: miRNA, Gene, RNA, Protein
7245 a(HGNC :L1CAM) -> path(DO:cancer) Abundance HGNC:L1CAM should be encoded as one of: miRNA, Gene, RNA, Protein
7246 UNSET Pathway "Pathway" is not defined
7252 SET Pathway = "Wnt/beta-catenin/tcf signaling pathway" "Pathway" is not defined
7254 a(HGNC:TDGF1) -> path(DO:cancer) Abundance HGNC:TDGF1 should be encoded as one of: miRNA, Gene, RNA, Protein
7257 a(HGNC:TDGF1) -- path(MESHD:"Colorectal Neoplasms") Abundance HGNC:TDGF1 should be encoded as one of: miRNA, Gene, RNA, Protein
7258 a(HGNC:TDGF1) -- path(DO:"liver cancer") Abundance HGNC:TDGF1 should be encoded as one of: miRNA, Gene, RNA, Protein
7262 SET Pathway = "Wnt/beta-catenin/tcf signaling pathway" "Pathway" is not defined
7271 SET Pathway = "Wnt/beta-catenin/tcf signaling pathway" "Pathway" is not defined
7278 bp(GOBP:"Wnt signaling pathway") -- bp(GOBP:"oncogenesis") "oncogenesis" is not in the GOBP namespace
7286 bp(GO:"Wnt receptor signaling pathway") -- p(HGNC:AR) "GO" is not a defined namespace
7289 bp(GO:"Wnt receptor signaling pathway") -- tscript(p(HGNC:AR)) "GO" is not a defined namespace
7290 bp(GO:"Wnt receptor signaling pathway") -> bp(GO:"cell proliferation") "GO" is not a defined namespace
7291 bp(GO:"Wnt receptor signaling pathway") -> path(SDIS:"carcinoma of prostate gland") "GO" is not a defined namespace
7307 p(HGNC:CTNNB1) -- p(HGNC:GRRARB) "GRRARB" is not in the HGNC namespace
7309 p(HGNC:CTNNB1) -- p(HGNC:TR) "TR" is not in the HGNC namespace
7310 p(HGNC:CTNNB1) -- p(HGNC:ER) "ER" is not in the HGNC namespace
7311 p(HGNC:CTNNB1) -- p(HGNC:PPAR) "PPAR" is not in the HGNC namespace
7327 a(HGNC:SOX2)-> bp(MESHPP:"Embryonic Development") Abundance HGNC:SOX2 should be encoded as one of: miRNA, Gene, RNA, Protein
7330 a(HGNC:SOX2) =| bp(GOBP:"Wnt signaling pathway") Abundance HGNC:SOX2 should be encoded as one of: miRNA, Gene, RNA, Protein
7333 SET CardiovascularSystem = "Heart" "CardiovascularSystem" is not defined
7334 SET BodyRegion = "ventricle" "BodyRegion" is not defined
7335 a(HGNC:SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7341 path(DO:"pancreatic cancer") -> a(HGNC: SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7342 path(DO:"gastric cancer") -> a(HGNC: SOX7) "gastric cancer" is not in the DO namespace
7343 path(DO:"esophagel cancer") -> a(HGNC: SOX7) "esophagel cancer" is not in the DO namespace
7347 path(MESHD:"Colorectal Neoplasms") -| a(HGNC: SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7348 path(DO:"breastcancer") -| a(HGNC: SOX7) "breastcancer" is not in the DO namespace
7349 path(DO:"kidney sarcoma") -| a(HGNC: SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7350 path(DO:"lung cancer") -| a(HGNC: SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7351 path(DO:"prostate cancer") -| a(HGNC: SOX7) Abundance HGNC:SOX7 should be encoded as one of: miRNA, Gene, RNA, Protein
7376 SET Tissue = "intestinal epithelium" "Tissue" is not defined
7380 UNSET Tissue "Tissue" is not defined
7426 SET Cell = "colon epithelium" "colon epithelium" is not defined in the Cell annotation
7433 UNSET Cell "Cell" is not set, so it can't be unset
7434 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7446 UNSET DigestiveSystem "DigestiveSystem" is not defined
7447 SET CellLine = "293" "293" is not defined in the CellLine annotation
7453 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7463 UNSET DigestiveSystem "DigestiveSystem" is not defined
7474 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7510 p(HGNC:TGFB1) -| bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
7536 SET BodyRegion = "intestine" "BodyRegion" is not defined
7543 UNSET BodyRegion "BodyRegion" is not defined
7544 SET CellLine = "SW480 cell line" "SW480 cell line" is not defined in the CellLine annotation
7560 a(CHEBI:indomethacin) -| tscript(p(SFAM:"TCF/LEF Family")) "indomethacin" is not in the CHEBI namespace
7565 a(CHEBI:indomethacin) -| r(HGNC:CCND1) "indomethacin" is not in the CHEBI namespace
7580 a(CHEBI:indomethacin) -| tscript(p(SFAM:"TCF/LEF Family")) "indomethacin" is not in the CHEBI namespace
7588 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
7589 SET BodyRegion = "Breast" "BodyRegion" is not defined
7596 UNSET BodyRegion "BodyRegion" is not defined
7597 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7601 UNSET Disease "Disease" is not set, so it can't be unset
7602 UNSET DigestiveSystem "DigestiveSystem" is not defined
7603 SET Cell = "Macrophages" "Macrophages" is not defined in the Cell annotation
7661 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
7662 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7669 UNSET Disease "Disease" is not set, so it can't be unset
7670 UNSET DigestiveSystem "DigestiveSystem" is not defined
7702 p(HGNC:ABCB1) -- bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
7703 p(HGNC:TCF7L2) -- bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
7708 bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
7740 SET Cell = "embryonic kidney cell" "embryonic kidney cell" is not defined in the Cell annotation
7748 UNSET Cell "Cell" is not set, so it can't be unset
7766 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
7771 cat(p(HGNC:CYP3A)) -> path(SDIS:"Paclitaxel resistance") Protein HGNC:CYP3A should be encoded as one of: Gene
7836 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
7837 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
7866 UNSET Disease "Disease" is not set, so it can't be unset
7870 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
7879 UNSET Disease "Disease" is not set, so it can't be unset
7880 UNSET DigestiveSystem "DigestiveSystem" is not defined
7894 SET CellLine = "293" "293" is not defined in the CellLine annotation
7995 tscript(p(HGNC:MYC)) -> bp(GOBP:"positive regulation of S phase of mitotic cell cycle") "positive regulation of S phase of mitotic cell cycle" is not in the GOBP namespace
8078 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8079 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8122 p(HGNC:CTNNB1) -> bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
8130 bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
8164 kin(complex(SCOMP:"p85/p110 PI3Kinase Complex")) -| (tscript(p(SFAM:"NOTCH Family")) -| bp(GOBP:"Wnt receptor signaling pathway")) "Wnt receptor signaling pathway" is not in the GOBP namespace
8168 tscript(p(SFAM:"NOTCH Family")) -| bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
8179 SET IntegumentarySystem = "Skin" "IntegumentarySystem" is not defined
8183 UNSET IntegumentarySystem "IntegumentarySystem" is not defined
8209 bp(GOBP:"Wnt receptor signaling pathway") -- path(SDIS:"carcinoma of liver") "Wnt receptor signaling pathway" is not in the GOBP namespace
8210 tscript(p(SFAM:"NOTCH Family")) -| bp(GOBP:"Wnt receptor signaling pathway") "Wnt receptor signaling pathway" is not in the GOBP namespace
8213 SET IntegumentarySystem = "Skin" "IntegumentarySystem" is not defined
8225 UNSET IntegumentarySystem "IntegumentarySystem" is not defined
8238 SET IntegumentarySystem = "Skin" "IntegumentarySystem" is not defined
8244 UNSET IntegumentarySystem "IntegumentarySystem" is not defined
8268 SET Cell = "Keratinocytes" "Keratinocytes" is not defined in the Cell annotation
8277 UNSET Cell "Cell" is not set, so it can't be unset
8302 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8303 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8334 UNSET Disease "Disease" is not set, so it can't be unset
8338 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8354 UNSET Disease "Disease" is not set, so it can't be unset
8355 UNSET DigestiveSystem "DigestiveSystem" is not defined
8360 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8361 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8377 UNSET Disease "Disease" is not set, so it can't be unset
8378 UNSET DigestiveSystem "DigestiveSystem" is not defined
8388 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8389 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8423 UNSET Disease "Disease" is not set, so it can't be unset
8424 UNSET DigestiveSystem "DigestiveSystem" is not defined
8430 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8431 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8445 p(HGNC:MTHFD1L) -> path(SDIS:"aSCOMPorage-independent growth") "aSCOMPorage-independent growth" is not in the SDIS namespace
8471 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8472 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8483 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8506 a(CHEBI:indomethacin) -> r(HGNC:PTEN) "indomethacin" is not in the CHEBI namespace
8514 SET Cell = "Fibroblasts" "Fibroblasts" is not defined in the Cell annotation
8515 SET RespiratorySystem = "Lung" "RespiratorySystem" is not defined
8531 SET Disease = "Neoplasms" "Neoplasms" is not defined in the Disease annotation
8532 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8540 UNSET Disease "Disease" is not set, so it can't be unset
8541 UNSET DigestiveSystem "DigestiveSystem" is not defined
8620 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
8627 UNSET DigestiveSystem "DigestiveSystem" is not defined
8637 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
8696 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
8702 UNSET CellLine "CellLine" is not set, so it can't be unset
8716 SET CellLine = "HCT116 cell line" "HCT116 cell line" is not defined in the CellLine annotation
8744 SET UrogenitalSystem = "Uterus" "UrogenitalSystem" is not defined
8776 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
8797 p(HGNC:C4orf34) "C4orf34" is not in the HGNC namespace
8803 SET CellLine = "HCT116 cell line" "HCT116 cell line" is not defined in the CellLine annotation
8873 a(SCHEM:Fluorouracil) -> r(HGNC:C10orf118) "C10orf118" is not in the HGNC namespace
8874 a(SCHEM:Fluorouracil) -> r(HGNC:C4orf34) "C4orf34" is not in the HGNC namespace
8907 a(SCHEM:Fluorouracil) -> r(HGNC:ZNF238) "ZNF238" is not in the HGNC namespace
8910 UNSET CellLine "CellLine" is not set, so it can't be unset
8922 p(EGID:100130522) Protein EGID:100130522 should be encoded as one of: miRNA, Gene, RNA
8934 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
8951 UNSET CellLine "CellLine" is not set, so it can't be unset
8955 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
8965 SET BodyRegion = "intestine" "BodyRegion" is not defined
9187 bp(GOBP:"age-dependent telomere shortening") -> bp(GOBP:"cell aging") "age-dependent telomere shortening" is not in the GOBP namespace
9193 complex(complex(p(HGNC:STAT3),p(HGNC:JUN)),g(HGNC:FAS)) [pos:16] "p" should be qualified with a valid namespace
9213 complex(complex(p(HGNC:STAT3),p(HGNC:CCND1)),g(HGNC:CDKN1A)) [pos:16] "p" should be qualified with a valid namespace
9241 cat(p(HGNC:TERT)) -| bp(GOBP:"age-dependent telomere shortening") "age-dependent telomere shortening" is not in the GOBP namespace
9243 tscript(p(HGNC:STAT3)) -| bp(GOBP:"age-dependent telomere shortening") "age-dependent telomere shortening" is not in the GOBP namespace
9284 SET Disease = "carcinoma of breast" "carcinoma of breast" is not defined in the Disease annotation
9288 UNSET Disease "Disease" is not set, so it can't be unset
9307 SET DigestiveSystem = "Liver" "DigestiveSystem" is not defined
9311 UNSET DigestiveSystem "DigestiveSystem" is not defined
9374 SET Disease = "carcinoma of breast" "carcinoma of breast" is not defined in the Disease annotation
9378 SET Disease = "Glioma" "Glioma" is not defined in the Disease annotation
9382 UNSET Disease "Disease" is not set, so it can't be unset
9395 SET Disease = "carcinoma of kidney" "carcinoma of kidney" is not defined in the Disease annotation
9399 SET Disease = "Multiple Myeloma" "Multiple Myeloma" is not defined in the Disease annotation
9403 UNSET Disease "Disease" is not set, so it can't be unset
9413 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
9428 SET Cell = "Stem Cells" "Stem Cells" is not defined in the Cell annotation
9459 SET CellLine = "carcinoma of colon" "carcinoma of colon" is not defined in the CellLine annotation
9490 SET Disease = "Carcinoma, Non-Small-Cell Lung" "Carcinoma, Non-Small-Cell Lung" is not defined in the Disease annotation
9491 SET RespiratorySystem = "Lung" "RespiratorySystem" is not defined
9498 UNSET Disease "Disease" is not set, so it can't be unset
9503 SET CellLine = "H1752" "H1752" is not defined in the CellLine annotation
9504 SET Disease = "Lung Neoplasms" "Lung Neoplasms" is not defined in the Disease annotation
9510 UNSET Disease "Disease" is not set, so it can't be unset
9516 SET CellLine = "Calu-1 cell line" "Calu-1 cell line" is not defined in the CellLine annotation
9520 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9528 SET CellLine = "Calu-1 cell line" "Calu-1 cell line" is not defined in the CellLine annotation
9532 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9537 SET Disease = "Lung Neoplasms" "Lung Neoplasms" is not defined in the Disease annotation
9542 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9550 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9558 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9572 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9580 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9584 SET CellLine = "H1752" "H1752" is not defined in the CellLine annotation
9589 UNSET Disease "Disease" is not set, so it can't be unset
9590 UNSET RespiratorySystem "RespiratorySystem" is not defined
9591 SET CellLine = "SW480 cell line" "SW480 cell line" is not defined in the CellLine annotation
9597 SET Disease = "Lung Neoplasms" "Lung Neoplasms" is not defined in the Disease annotation
9598 SET RespiratorySystem = "Lung" "RespiratorySystem" is not defined
9603 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9611 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9625 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9633 SET CellLine = "H1299 cell line" "H1299 cell line" is not defined in the CellLine annotation
9638 UNSET Disease "Disease" is not set, so it can't be unset
9643 UNSET RespiratorySystem "RespiratorySystem" is not defined
9647 SET RespiratorySystem = "Lung" "RespiratorySystem" is not defined
9685 complex(p(HGNC:BIRC5),p(HGNC:HBXIP)) =| cat(p(HGNC:CASP9)) "HBXIP" is not in the HGNC namespace
9765 SET CellLine = "HCT116 cell line" "HCT116 cell line" is not defined in the CellLine annotation
9774 SET CellLine = "HCT116 cell line" "HCT116 cell line" is not defined in the CellLine annotation
9793 SET Disease = "Neoplasm" "Neoplasm" is not defined in the Disease annotation
9794 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
9808 SET Disease = "Neoplasm" "Neoplasm" is not defined in the Disease annotation
9809 SET DigestiveSystem = "Colon" "DigestiveSystem" is not defined
9817 UNSET DigestiveSystem "DigestiveSystem" is not defined
9818 SET Disease = "carcinoma of breast" "carcinoma of breast" is not defined in the Disease annotation
9828 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9835 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9839 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9843 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9847 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9851 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9855 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9859 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9863 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9867 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9871 SET CellLine = "LoVo cell line" "LoVo cell line" is not defined in the CellLine annotation
9875 SET CellLine = "RKO cell line" "RKO cell line" is not defined in the CellLine annotation
9897 SET CellLine = "DLD-1 cell line" "DLD-1 cell line" is not defined in the CellLine annotation
9934 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
9941 UNSET Disease "Disease" is not set, so it can't be unset
9953 g(HGNC:KRAS) -- a("Survival Rate") [pos:18] "Survival Rate" should be qualified with a valid namespace
9954 g(HGNC:BRAF) -- a("Survival Rate") [pos:18] "Survival Rate" should be qualified with a valid namespace
9955 g(HGNC:PIK3CA) -- a("Relapse Time") [pos:20] "Relapse Time" should be qualified with a valid namespace
9956 g(HGNC:KRAS) -- a("Relapse Time") [pos:18] "Relapse Time" should be qualified with a valid namespace
9957 g(HGNC:BRAF) -- a("Relapse Time") [pos:18] "Relapse Time" should be qualified with a valid namespace
9974 SET Disease = {"Adenoma, Villous","Adenocarcinoma"} "Adenoma, Villous" is not defined in the Disease annotation
9983 UNSET Disease "Disease" is not set, so it can't be unset
9994 SET Disease = {"Adenoma, Villous","Adenocarcinoma"} "Adenoma, Villous" is not defined in the Disease annotation
10000 UNSET Disease "Disease" is not set, so it can't be unset
10003 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10007 UNSET Disease "Disease" is not set, so it can't be unset
10017 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10020 UNSET Disease "Disease" is not set, so it can't be unset
10028 g(HGNC:KRAS) -- a("Survival Rate") [pos:18] "Survival Rate" should be qualified with a valid namespace
10075 SET CarcinomaType= "lateral spreading tumors-granular" "CarcinomaType" is not defined
10080 UNSET CarcinomaType "CarcinomaType" is not defined
10082 SET CarcinomaType= "lateral spreading tumors" "CarcinomaType" is not defined
10085 UNSET CarcinomaType "CarcinomaType" is not defined
10097 SET CarcinomaType= "depressed neoplasms" "CarcinomaType" is not defined
10099 UNSET CarcinomaType "CarcinomaType" is not defined
10110 SET CarcinomaType= {"depressed neoplasms","lateral spreading tumors-granular"} "CarcinomaType" is not defined
10112 UNSET CarcinomaType "CarcinomaType" is not defined
10113 SET CarcinomaType= "lateral spreading tumors-granular" "CarcinomaType" is not defined
10115 UNSET CarcinomaType "CarcinomaType" is not defined
10142 SET CarcinomaType= "nonpolypoid Neoplasms" "CarcinomaType" is not defined
10146 UNSET CarcinomaType "CarcinomaType" is not defined
10154 SET CarcinomaType= {"depressed neoplasms","lateral spreading tumors-non-granular", "nonpolypoid Neoplasms"} "CarcinomaType" is not defined
10156 UNSET CarcinomaType "CarcinomaType" is not defined
10163 SET Evidence = "Evidence" is not defined
10164 "Laterally spreading tumours (LSTs) are a heterogeneous group of adenomas that are emerging as important precursors of colorectal cancer and in which the risk for cancer is related to their endoscopically definable morphology." General Parser Failure on line 10164 at pos 0: "Laterally spreading tumours (LSTs) are a heterogeneous group of adenomas that are emerging as important precursors of colorectal cancer and in which the risk for cancer is related to their endoscopically definable morphology."
10174 SET CarcinomaType= "lateral spreading tumors" "CarcinomaType" is not defined
10179 UNSET CarcinomaType "CarcinomaType" is not defined
10184 SET CarcinomaType= "lateral spreading tumors-granular" "CarcinomaType" is not defined
10186 UNSET CarcinomaType "CarcinomaType" is not defined
10192 SET CarcinomaType = "lateral spreading tumors" "CarcinomaType" is not defined
10195 UNSET CarcinomaType "CarcinomaType" is not defined
10221 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10227 UNSET Disease "Disease" is not set, so it can't be unset
10245 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10249 UNSET Disease "Disease" is not set, so it can't be unset
10259 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10276 UNSET Disease "Disease" is not set, so it can't be unset
10295 SET AdenomaType= "familial adenoma" "AdenomaType" is not defined
10300 UNSET AdenomaType "AdenomaType" is not defined
10330 SET AdenomaType= "familial adenoma" "AdenomaType" is not defined
10335 UNSET AdenomaType "AdenomaType" is not defined
10339 SET CarcinomaType= "familial Carcinoma" "CarcinomaType" is not defined
10341 UNSET CarcinomaType "CarcinomaType" is not defined
10352 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10356 p(HGNC:APC, sub(Y, 94, X)) -- path(MESHD:"Colorectal Neoplasms") [pos:23] Placeholder amino acid found: X
10360 UNSET Disease "Disease" is not set, so it can't be unset
10368 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10369 SET FluidAndSecretion = "Serum" "FluidAndSecretion" is not defined
10370 act(a(sulfatase)) positiveCorrelation path(MESHD:"Colorectal Neoplasms") [pos:6] "sulfatase" should be qualified with a valid namespace
10371 UNSET Disease "Disease" is not set, so it can't be unset
10372 SET Disease = "Adenoma" "Adenoma" is not defined in the Disease annotation
10373 act(a(sulfatase)) positiveCorrelation path(MESHD:Adenoma) [pos:6] "sulfatase" should be qualified with a valid namespace
10375 UNSET FluidAndSecretion "FluidAndSecretion" is not defined
10376 UNSET Disease "Disease" is not set, so it can't be unset
10388 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10392 UNSET Disease "Disease" is not set, so it can't be unset
10403 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10407 UNSET Disease "Disease" is not set, so it can't be unset
10413 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10414 path(MESHD:"Crohn Disease") negativeCorrelation a("Survival Rate") [pos:50] "Survival Rate" should be qualified with a valid namespace
10417 p(HGNC:MUC5AC) negativeCorrelation a("Survival Rate") [pos:37] "Survival Rate" should be qualified with a valid namespace
10419 UNSET Disease "Disease" is not set, so it can't be unset
10431 composite(p(HGNC:ERBB3) , p(HGNC:EGFR)) -> p(PFH:"MAPK Erk1/3 Family") "PFH" is not a defined namespace
10444 a(panitumumab) -- bp(GOBP:"epidermal growth factor receptor signaling pathway") [pos:2] "panitumumab" should be qualified with a valid namespace
10465 g("mismatch repair genes") -- path(MESHD:"Colorectal Neoplasms") [pos:2] "mismatch repair genes" should be qualified with a valid namespace
10500 g(dbSNP:rs1801274) -- g(HGNC:FCGR2A) "dbSNP" is not a defined namespace
10501 g(dbSNP:rs396991) -- g(HGNC:FCGR3A) "dbSNP" is not a defined namespace
10502 g(dbSNP:rs396991) -- a(SCHEM:Cetuximab) "dbSNP" is not a defined namespace
10503 g(dbSNP:rs1801274) -- a(SCHEM:Cetuximab) "dbSNP" is not a defined namespace
10511 g(dbSNP:rs396991) causesNoChange a(SCHEM:Cetuximab) "dbSNP" is not a defined namespace
10523 g(HGNC:TP53) -- a(Chemoresistance) [pos:18] "Chemoresistance" should be qualified with a valid namespace
10535 p(HGNC:TP53, sub(R, 273, H)) -> a(Chemoresistance) [pos:34] "Chemoresistance" should be qualified with a valid namespace
10549 a("(131)I-antiEGFR-BSA-PCL") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "(131)I-antiEGFR-BSA-PCL" should be qualified with a valid namespace
10572 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10573 SET CellType= "Cancerous" "CellType" is not defined
10575 a(spicatoside) -> bp(GOBP:"cell death") [pos:2] "spicatoside" should be qualified with a valid namespace
10576 a(spicatoside) -| bp(GOBP:"cell growth") [pos:2] "spicatoside" should be qualified with a valid namespace
10577 UNSET CellType "CellType" is not defined
10578 UNSET Disease "Disease" is not set, so it can't be unset
10585 a(spicatoside) -- bp(GOBP:"apoptotic process") [pos:2] "spicatoside" should be qualified with a valid namespace
10591 a(spicatoside) -- p(HGNC:BCL2) [pos:2] "spicatoside" should be qualified with a valid namespace
10592 a(spicatoside) -- p(HGNC:BAX) [pos:2] "spicatoside" should be qualified with a valid namespace
10593 a(spicatoside) -- p(HGNC:BID) [pos:2] "spicatoside" should be qualified with a valid namespace
10594 a(spicatoside) -- bp(GOBP:"release of cytochrome c from mitochondria") [pos:2] "spicatoside" should be qualified with a valid namespace
10595 a(spicatoside) -- p(HGNC:PARP1) [pos:2] "spicatoside" should be qualified with a valid namespace
10603 g(HGNC:NFE2L2) negativeCorrelation a("Treatment outcome") [pos:37] "Treatment outcome" should be qualified with a valid namespace
10611 SET CellType = "Cancerous" "CellType" is not defined
10617 UNSET CellType "CellType" is not defined
10620 SET CellType = "Cancerous" "CellType" is not defined
10626 UNSET CellType "CellType" is not defined
10632 SET CellType = "Cancerous" "CellType" is not defined
10634 a("Survival Rate") negativeCorrelation p(HGNC:NFE2L2) [pos:2] "Survival Rate" should be qualified with a valid namespace
10636 UNSET CellType "CellType" is not defined
10671 SET GenoType = "cNrf2" "GenoType" is not defined
10672 p(HGNC:CTNNB1) -- a("Survival Rate") [pos:20] "Survival Rate" should be qualified with a valid namespace
10673 p(HGNC:PSMD4) -- a("Survival Rate") [pos:19] "Survival Rate" should be qualified with a valid namespace
10674 UNSET GenoType "GenoType" is not defined
10685 SET CellType= "Cancerous" "CellType" is not defined
10688 UNSET CellType "CellType" is not defined
10695 a(XGFR) -| p(HGNC:EGFR,pmod(P)) [pos:2] "XGFR" should be qualified with a valid namespace
10696 a(XGFR) -| p(HGNC:IGF1R,pmod(P)) [pos:2] "XGFR" should be qualified with a valid namespace
10698 SET CellType = "Cancerous" "CellType" is not defined
10699 a(XGFR) -| bp(GOBP:"cell growth") [pos:2] "XGFR" should be qualified with a valid namespace
10700 UNSET CellType "CellType" is not defined
10709 a(XGFR) -| path(MESHD:"Pancreatic Neoplasms") [pos:2] "XGFR" should be qualified with a valid namespace
10741 g(HGNC:KRAS) -- p(PFH:"EGFR/ERBB Family") "PFH" is not a defined namespace
10767 a("MM-1151") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "MM-1151" should be qualified with a valid namespace
10785 p(HGNC:KRAS, sub(G, 12 ,D)) -| a("Survival Rate") [pos:33] "Survival Rate" should be qualified with a valid namespace
10786 g(HGNC:BRAF) -- a("Survival Rate") [pos:18] "Survival Rate" should be qualified with a valid namespace
10832 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
10835 UNSET Disease "Disease" is not set, so it can't be unset
10850 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
10852 UNSET CarcinomaType "CarcinomaType" is not defined
10922 a("Crataegus azarolus ethyl acetate") -- p(HGNC:PARP1) [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10923 a("Crataegus azarolus ethyl acetate") -- p(HGNC:CASP8) [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10924 a("Crataegus azarolus ethyl acetate") -| p(HGNC:BAX) [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10925 a("Crataegus azarolus ethyl acetate") -- bp(GOBP:"extrinsic apoptotic signaling pathway") [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10926 a("Crataegus azarolus ethyl acetate") -- p(HGNC:CDKN1A) [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10927 a("Crataegus azarolus ethyl acetate") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "Crataegus azarolus ethyl acetate" should be qualified with a valid namespace
10936 g(HGNC:TP53) -- a(Chemoresistance) [pos:18] "Chemoresistance" should be qualified with a valid namespace
10943 g(HGNC:EFNB2) -- a(Chemoresistance) [pos:19] "Chemoresistance" should be qualified with a valid namespace
10954 SET GenoType = "mutant TP53" "GenoType" is not defined
10956 UNSET GenoType "GenoType" is not defined
10974 a(Geitinib) -| p(HGNC:EGFR) [pos:2] "Geitinib" should be qualified with a valid namespace
10982 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| bp(GOBP:"cell growth") [pos:39] "Geitinib" should be qualified with a valid namespace
10983 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| bp(GOBP:"cell cycle") [pos:39] "Geitinib" should be qualified with a valid namespace
10984 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -> bp(GOBP:"apoptotic process") [pos:39] "Geitinib" should be qualified with a valid namespace
10993 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| bp(GOBP:"DNA replication") [pos:39] "Geitinib" should be qualified with a valid namespace
10994 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| p(HGNC:CCND1) [pos:39] "Geitinib" should be qualified with a valid namespace
10995 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| p(HGNC:STAT3, pmod(P)) [pos:39] "Geitinib" should be qualified with a valid namespace
10996 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| p(HGNC:EGFR, pmod(P)) [pos:39] "Geitinib" should be qualified with a valid namespace
10997 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| p(HGNC:CDKN1B) [pos:39] "Geitinib" should be qualified with a valid namespace
11010 composite(a(CHEBI:"cucurbitacin B"), a(Geitinib)) -| path(MESHD:"Colorectal Neoplasms") [pos:39] "Geitinib" should be qualified with a valid namespace
11033 SET GenoType = "RAS wild type" "GenoType" is not defined
11034 SET CarcinomaType= "Metastatic" "CarcinomaType" is not defined
11035 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
11036 a("anti-EGFR moAb") -> a("Survival Rate") [pos:2] "anti-EGFR moAb" should be qualified with a valid namespace
11037 UNSET GenoType "GenoType" is not defined
11038 UNSET CarcinomaType "CarcinomaType" is not defined
11039 UNSET Disease "Disease" is not set, so it can't be unset
11047 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11050 UNSET CarcinomaType "CarcinomaType" is not defined
11093 SET CarcinomaType= "Sporadic" "CarcinomaType" is not defined
11098 UNSET CarcinomaType "CarcinomaType" is not defined
11107 SET GenoType = {"NRAS wild-type", "KRAS wild-type"} "GenoType" is not defined
11109 UNSET GenoType "GenoType" is not defined
11132 SET CarcinomaType = {"Metastatic", "primary"} "CarcinomaType" is not defined
11135 UNSET CarcinomaType "CarcinomaType" is not defined
11143 a("mAb198.3") -| p(HGNC:FAT1) [pos:2] "mAb198.3" should be qualified with a valid namespace
11145 SET CellType = "Cancerous" "CellType" is not defined
11146 a("mAb198.3") -| bp(GOBP:"cell growth") [pos:2] "mAb198.3" should be qualified with a valid namespace
11147 UNSET CellType "CellType" is not defined
11166 bp("MAPK pathway") -- path(MESHD:"Colorectal Neoplasms") [pos:3] "MAPK pathway" should be qualified with a valid namespace
11168 g(HGNC:KRAS) -- bp("MAPK pathway") [pos:19] "MAPK pathway" should be qualified with a valid namespace
11170 g(HGNC:BRAF) -- bp("MAPK pathway") [pos:19] "MAPK pathway" should be qualified with a valid namespace
11172 g(HGNC:NRAS) -- bp("MAPK pathway") [pos:19] "MAPK pathway" should be qualified with a valid namespace
11201 SET Gender = "Female" "Gender" is not defined
11202 path(MESHD:"Carcinoma, Medullary") -- a("Colon, Ascending") [pos:40] "Colon, Ascending" should be qualified with a valid namespace
11203 UNSET Gender "Gender" is not defined
11212 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11214 UNSET CarcinomaType "CarcinomaType" is not defined
11235 SET AdenomaType = "Sessile serrated" "AdenomaType" is not defined
11237 UNSET AdenomaType "AdenomaType" is not defined
11239 SET CancerCause = "Sessile serrated adenoma" "CancerCause" is not defined
11242 path(MESHD:"Colorectal Neoplasms") -- a("Colon, Ascending") [pos:40] "Colon, Ascending" should be qualified with a valid namespace
11243 UNSET CancerCause "CancerCause" is not defined
11256 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11257 SET GenoType = "RAS wild type" "GenoType" is not defined
11258 SET ClinicalResult = "early tumor shrinkage" "ClinicalResult" is not defined
11260 a(SCHEM:Cetuximab) -> a("Survival Rate") [pos:24] "Survival Rate" should be qualified with a valid namespace
11261 UNSET CarcinomaType "CarcinomaType" is not defined
11262 UNSET GenoType "GenoType" is not defined
11263 UNSET ClinicalResult "ClinicalResult" is not defined
11285 a("K-756") -| p(HGNC:TNKS) [pos:2] "K-756" should be qualified with a valid namespace
11288 p(HGNC:TNKS) isA p(PARP) [pos:19] "PARP" should be qualified with a valid namespace
11294 SET CellLine = {"COLO 320DM", "SW403"} "COLO 320DM" is not defined in the CellLine annotation
11295 SET CancerCause = "APC-mutant" "CancerCause" is not defined
11296 a("K-756") -| bp(GOBP:"Wnt signaling pathway") [pos:2] "K-756" should be qualified with a valid namespace
11298 UNSET CancerCause "CancerCause" is not defined
11299 UNSET CellLine "CellLine" is not set, so it can't be unset
11315 a("Fibersol-2") -> a(CHEBI:"reactive oxygen species") [pos:2] "Fibersol-2" should be qualified with a valid namespace
11317 a("Fibersol-2") -| path(MESHD:Adenoma) [pos:2] "Fibersol-2" should be qualified with a valid namespace
11320 a("Fibersol-2") -| path(MESHD:Neoplasms) [pos:2] "Fibersol-2" should be qualified with a valid namespace
11397 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
11400 UNSET Disease "Disease" is not set, so it can't be unset
11408 a(NT157) -| p(HGNC:IGF1) [pos:2] "NT157" should be qualified with a valid namespace
11409 a(NT157) -| p(HGNC:STAT3) [pos:2] "NT157" should be qualified with a valid namespace
11416 a(NT157) -| path(MESHD:Neoplasms) [pos:2] "NT157" should be qualified with a valid namespace
11417 a(NT157) -| p(HGNC:IL6) [pos:2] "NT157" should be qualified with a valid namespace
11418 a(NT157) -| p(HGNC:IL11) [pos:2] "NT157" should be qualified with a valid namespace
11419 a(NT157) -| p(HGNC:IL23A) [pos:2] "NT157" should be qualified with a valid namespace
11420 a(NT157) -| p(HGNC:CCL2) [pos:2] "NT157" should be qualified with a valid namespace
11421 a(NT157) -| p(HGNC:CCL7) [pos:2] "NT157" should be qualified with a valid namespace
11422 a(NT157) -| p(HGNC:CCL5) [pos:2] "NT157" should be qualified with a valid namespace
11423 a(NT157) -| p(HGNC:CXCL5) [pos:2] "NT157" should be qualified with a valid namespace
11424 a(NT157) -| p(HGNC:ICAM1) [pos:2] "NT157" should be qualified with a valid namespace
11425 a(NT157) -| p(HGNC:TGFB1) [pos:2] "NT157" should be qualified with a valid namespace
11437 SET GenoType = "mutant KRAS" "GenoType" is not defined
11442 UNSET GenoType "GenoType" is not defined
11451 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
11452 g(HGNC:MYB) positiveCorrelation a("cancer relapse") [pos:34] "cancer relapse" should be qualified with a valid namespace
11453 UNSET Disease "Disease" is not set, so it can't be unset
11468 SET CarcinomaType = "signet ring cell carcinoma" "CarcinomaType" is not defined
11470 UNSET CarcinomaType "CarcinomaType" is not defined
11479 SET CarcinomaType = "signet ring cell carcinoma" "CarcinomaType" is not defined
11482 UNSET CarcinomaType "CarcinomaType" is not defined
11496 a("monoclonal antibodies") -| p(HGNC:EGFR) [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11500 a("Cytotoxic agents") hasMember list(a(CHEBI:"5-fluorouracil"), a(CHEBI:oxaliplatin), a(CHEBI:Irinotecan)) [pos:2] "Cytotoxic agents" should be qualified with a valid namespace
11501 composite(a("Cytotoxic agents"), a("monoclonal antibodies")) -> a("Treatment side effects") [pos:12] "Cytotoxic agents" should be qualified with a valid namespace
11510 SET Disease = "Anus Neoplasms" "Anus Neoplasms" is not defined in the Disease annotation
11511 SET CarcinomaType= "Metastatic" "CarcinomaType" is not defined
11513 UNSET Disease "Disease" is not set, so it can't be unset
11514 UNSET TumoreType "TumoreType" is not defined
11520 SET Disease = "Anus Neoplasms" "Anus Neoplasms" is not defined in the Disease annotation
11523 UNSET Disease "Disease" is not set, so it can't be unset
11533 SET GenoType = "mutant KRAS" "GenoType" is not defined
11534 SET MutationSite = "Cell-free DNA" "MutationSite" is not defined
11535 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11537 UNSET GenoType "GenoType" is not defined
11538 UNSET MutationSite "MutationSite" is not defined
11539 UNSET CarcinomaType "CarcinomaType" is not defined
11548 a("monoclonal antibodies") hasMember list(a(SCHEM:Cetuximab),a(SCHEM:Bevacizumab), a(ramucirumab), a(panitumumab)) [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11550 SET CarcinomaType= "Metastatic" "CarcinomaType" is not defined
11551 a("monoclonal antibodies") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11552 UNSET CarcinomaType "CarcinomaType" is not defined
11557 a("monoclonal antibodies") -> a("Survival Rate") [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11574 a(ramucirumab) -| p(HGNC:KDR) [pos:2] "ramucirumab" should be qualified with a valid namespace
11575 a(ramucirumab) -> path(MESHD:Proteinuria) [pos:2] "ramucirumab" should be qualified with a valid namespace
11576 a(ramucirumab) -> path(MESHD:Hypertension) [pos:2] "ramucirumab" should be qualified with a valid namespace
11585 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11587 a(panitumumab) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "panitumumab" should be qualified with a valid namespace
11588 UNSET CarcinomaType "CarcinomaType" is not defined
11590 a(CHEBI:"epidermal growth factor receptor antagonist") hasMember list(a(SCHEM:Cetuximab),a(SCHEM:Cetuximab)) General Parser Failure on line 11590 at pos 65: a(CHEBI:"epidermal growth factor receptor antagonist") hasMember list(a(SCHEM:Cetuximab),a(SCHEM:Cetuximab))
11595 a(Sym004) isA a(CHEBI:"epidermal growth factor receptor antagonist") [pos:2] "Sym004" should be qualified with a valid namespace
11596 a(Sym004) isA a("monoclonal antibodies") [pos:2] "Sym004" should be qualified with a valid namespace
11598 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11599 a("monoclonal antibodies") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11600 UNSET CarcinomaType "CarcinomaType" is not defined
11605 SET GenoType = "mutant EFGR" "GenoType" is not defined
11606 a(Sym004) -| p(HGNC:EGFR, pmod(P)) [pos:2] "Sym004" should be qualified with a valid namespace
11607 UNSET GenoType "GenoType" is not defined
11618 SET GenoType = "mutant EFGR" "GenoType" is not defined
11619 a(Sym004) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "Sym004" should be qualified with a valid namespace
11620 UNSET GenoType "GenoType" is not defined
11638 g(HGNC:NT5E) -> bp("beta-catenin signaling pathway") [pos:19] "beta-catenin signaling pathway" should be qualified with a valid namespace
11639 g(HGNC:NT5E) -> bp("cyclin D1 signaling pathway") [pos:19] "cyclin D1 signaling pathway" should be qualified with a valid namespace
11640 SET CellType = "Cancerous" "CellType" is not defined
11642 UNSET CellType "CellType" is not defined
11652 SET CancerStage = "stage III" "CancerStage" is not defined
11653 SET GenoType = "mutant KRAS" "GenoType" is not defined
11654 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
11655 a("tegafur-uracil") -> a("Survival Rate") [pos:2] "tegafur-uracil" should be qualified with a valid namespace
11656 a("tegafur-uracil") -- a("Relapse free survival") [pos:2] "tegafur-uracil" should be qualified with a valid namespace
11657 UNSET CancerStage "CancerStage" is not defined
11658 UNSET GenoType "GenoType" is not defined
11659 UNSET Disease "Disease" is not set, so it can't be unset
11669 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11670 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
11671 bp(GOBP:"antibody-dependent cellular cytotoxicity") positiveCorrelation a("Survival Rate") [pos:74] "Survival Rate" should be qualified with a valid namespace
11672 UNSET Disease "Disease" is not set, so it can't be unset
11673 UNSET CarcinomaType "CarcinomaType" is not defined
11686 SET GenoType = "KRAS wild-type" "GenoType" is not defined
11687 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11688 a("epidermal growth factor receptor antagonist") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "epidermal growth factor receptor antagonist" should be qualified with a valid namespace
11689 UNSET CarcinomaType "CarcinomaType" is not defined
11690 UNSET GenoType "GenoType" is not defined
11696 SET GenoType = {"mutant BRAF","mutant NRAS", "mutant PIK3CA", "PTEN-null"} "GenoType" is not defined
11698 a("epidermal growth factor receptor antagonist") causesNoChange path(MESHD:"Colorectal Neoplasms") [pos:2] "epidermal growth factor receptor antagonist" should be qualified with a valid namespace
11699 UNSET GenoType "GenoType" is not defined
11726 SET GenoType = "mutant RAS" "GenoType" is not defined
11737 SET AdenomaType= "familial adenoma" "AdenomaType" is not defined
11739 UNSET AdenomaType "AdenomaType" is not defined
11766 SET GenoType = "mutant KRAS" "GenoType" is not defined
11768 a(panitumumab) causesNoChange path(MESHD:"Colorectal Neoplasms") [pos:2] "panitumumab" should be qualified with a valid namespace
11769 UNSET GenoType "GenoType" is not defined
11777 SET GenoType = "mutant RAS" "GenoType" is not defined
11778 g(HGNC:KRAS) biomarkerFor a("Treatment outcome") General Parser Failure on line 11778 at pos 26: g(HGNC:KRAS) biomarkerFor a("Treatment outcome")
11779 g(HGNC:NRAS) biomarkerFor a("Treatment outcome") General Parser Failure on line 11779 at pos 26: g(HGNC:NRAS) biomarkerFor a("Treatment outcome")
11780 UNSET GenoType "GenoType" is not defined
11803 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
11804 SET GenoType = "mutant KRAS" "GenoType" is not defined
11805 a("monoclonal antibodies") causesNoChange path(MESHD:"Colorectal Neoplasms") [pos:2] "monoclonal antibodies" should be qualified with a valid namespace
11806 UNSET GenoType "GenoType" is not defined
11807 UNSET CarcinomaType "CarcinomaType" is not defined
11816 SET GenoType = {"mutant KRAS", "mutant BRAF"} "GenoType" is not defined
11818 UNSET GenoType "GenoType" is not defined
11837 SET GenoType = {"mutant KRAS", "mutant BRAF"} "GenoType" is not defined
11839 UNSET GenoType "GenoType" is not defined
11841 SET GenoType = {"mutant APC", "mutant KRAS"} "GenoType" is not defined
11842 SET CellType = "Cancerous" "CellType" is not defined
11844 UNSET CellType "CellType" is not defined
11845 UNSET GenoType "GenoType" is not defined
11855 g(HGNC:APC) -- p("beta-catenin destruction complex") [pos:17] "beta-catenin destruction complex" should be qualified with a valid namespace
11861 p(HGNC:TMEM201) -- p("beta-catenin destruction complex") [pos:21] "beta-catenin destruction complex" should be qualified with a valid namespace
11870 SET CarcinomaType = "Granule aggregating" "CarcinomaType" is not defined
11872 UNSET CarcinomaType "CarcinomaType" is not defined
11883 p(HGNC:NEO1) -- bp(astrogliogenesis) [pos:19] "astrogliogenesis" should be qualified with a valid namespace
11907 g(HGNC:DCC) -- g(dbSNP:rs2229080) "dbSNP" is not a defined namespace
11908 g(dbSNP:rs2229080) -- path(DO:schizophrenia) "dbSNP" is not a defined namespace
11917 g(HGNC:GSK3B) -- g(dbSNP:rs3755557) "dbSNP" is not a defined namespace
11918 g(dbSNP:rs3755557) negativeCorrelation path(DO:schizophrenia) "dbSNP" is not a defined namespace
11948 g(HGNC:DCC) -- g(dbSNP:rs714) "dbSNP" is not a defined namespace
11949 g(HGNC:PSCA) -- g(dbSNP:rs2976392) "dbSNP" is not a defined namespace
11950 g(HGNC:PSCA) -- g(dbSNP:rs2294008) "dbSNP" is not a defined namespace
11955 g(HGNC:DCC) -- g(dbSNP:rs714) "dbSNP" is not a defined namespace
11957 SET Race = "Asian" "Asian" is not defined in the Race annotation
11958 g(dbSNP:rs714) -> path(MESHD:Neoplasms) "dbSNP" is not a defined namespace
11959 UNSET Race "Race" is not set, so it can't be unset
11964 g(dbSNP:rs2294008) -> path(MESHD:Neoplasms) "dbSNP" is not a defined namespace
11969 g(dbSNP:rs2976392) causesNoChange path(MESHD:Neoplasms) "dbSNP" is not a defined namespace
11974 SET Race = "Asian" "Asian" is not defined in the Race annotation
11975 g(dbSNP:rs714) -> path(MESHD:"Gastrointestinal Neoplasms") "dbSNP" is not a defined namespace
11976 g(dbSNP:rs714) -> path(MESHD:"Urinary Bladder Neoplasms") "dbSNP" is not a defined namespace
11977 g(dbSNP:rs2294008) -> path(MESHD:"Gastrointestinal Neoplasms") "dbSNP" is not a defined namespace
11978 g(dbSNP:rs2294008) -> path(MESHD:"Urinary Bladder Neoplasms") "dbSNP" is not a defined namespace
11979 UNSET Race "Race" is not set, so it can't be unset
11989 SET Disease = {"Colorectal Neoplasms", "Breast Neoplasms"} "Colorectal Neoplasms" is not defined in the Disease annotation
11992 UNSET Disease "Disease" is not set, so it can't be unset
12008 SET VascularType = "O2-dependent vascular homeostasis" "VascularType" is not defined
12010 UNSET VascularType "VascularType" is not defined
12031 g(HGNC:OVOL2) negativeCorrelation a("CRC tumor stage") [pos:36] "CRC tumor stage" should be qualified with a valid namespace
12082 SET Race = {"Kazakh", "Russian"} "Kazakh" is not defined in the Race annotation
12087 UNSET Race "Race" is not set, so it can't be unset
12128 g(HGNC:DCC) -- g(dbSNP:rs2229080) "dbSNP" is not a defined namespace
12129 g(HGNC:DCC) -- g(dbSNP:rs714) "dbSNP" is not a defined namespace
12135 g(dbSNP:rs714) -- path(MESHD:"Esophageal Neoplasms") "dbSNP" is not a defined namespace
12136 g(dbSNP:rs714) -- path(MESHD:"Gastrointestinal Neoplasms") "dbSNP" is not a defined namespace
12140 g(dbSNP:rs2229080) causesNoChange path(MESHD:"Esophageal Neoplasms") "dbSNP" is not a defined namespace
12141 g(dbSNP:rs2229080) causesNoChange path(MESHD:"Gastrointestinal Neoplasms") "dbSNP" is not a defined namespace
12147 g(dbSNP:rs714) -> path(DO:"gastric adenocarcinoma") "dbSNP" is not a defined namespace
12148 g(dbSNP:rs714) -> path(DO:"gastric squamous cell carcinoma") "dbSNP" is not a defined namespace
12154 g(dbSNP:rs714) -- path(DO:cancer) "dbSNP" is not a defined namespace
12248 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
12249 SET CellType = "Cancerous" "CellType" is not defined
12252 UNSET CellType "CellType" is not defined
12253 UNSET Disease "Disease" is not set, so it can't be unset
12272 SET NervousSystem = "Brain" "NervousSystem" is not defined
12274 UNSET NervousSystem "NervousSystem" is not defined
12292 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
12294 g(HGNC:KRAS) -- a(panitumumab) [pos:18] "panitumumab" should be qualified with a valid namespace
12296 UNSET Disease "Disease" is not set, so it can't be unset
12321 p(HGNC:KRAS, sub(G,12,D)) -- path("Pulmonary enteric adenocarcinoma") [pos:34] "Pulmonary enteric adenocarcinoma" should be qualified with a valid namespace
12370 p("Receptor tyrosine kinases") -- bp("malignant transformation") [pos:2] "Receptor tyrosine kinases" should be qualified with a valid namespace
12377 a(Entrectinib) -| p(HGNC:ROS1) [pos:2] "Entrectinib" should be qualified with a valid namespace
12378 a(Entrectinib) -| p(HGNC:ALK) [pos:2] "Entrectinib" should be qualified with a valid namespace
12379 a(Entrectinib) -| p("Receptor tyrosine kinases") [pos:2] "Entrectinib" should be qualified with a valid namespace
12380 a(Entrectinib) -| path(MESHD:neoplasms) [pos:2] "Entrectinib" should be qualified with a valid namespace
12391 a(Entrectinib) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "Entrectinib" should be qualified with a valid namespace
12392 a(Entrectinib) -| path(MESHD:"Carcinoma, Non-Small-Cell Lung") [pos:2] "Entrectinib" should be qualified with a valid namespace
12421 SET CellType = "Cancerous" "CellType" is not defined
12422 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
12423 SET CancerCause = "EML4-ALK" "CancerCause" is not defined
12425 a(Entrectinib) -| bp(GOBP:"cell growth") [pos:2] "Entrectinib" should be qualified with a valid namespace
12426 UNSET CellType "CellType" is not defined
12427 UNSET Disease "Disease" is not set, so it can't be unset
12428 UNSET CancerCause "CancerCause" is not defined
12437 SET CancerCause = {"ALK rearrangments", "ROS1 rearrangement"} "CancerCause" is not defined
12439 UNSET CancerCause "CancerCause" is not defined
12474 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
12476 UNSET CarcinomaType "CarcinomaType" is not defined
12478 g(HGNC:ALK) -- a("anti-EGFR resistance") [pos:17] "anti-EGFR resistance" should be qualified with a valid namespace
12536 SET CellType = "Cancerous" "CellType" is not defined
12537 SET CarcinomaType = "VEGF-dependent" "CarcinomaType" is not defined
12538 complex(a(Aflibercept),p(HGNC:VEGFA)) -| bp(GOBP:"cell growth") [pos:10] "Aflibercept" should be qualified with a valid namespace
12539 UNSET CarcinomaType "CarcinomaType" is not defined
12540 UNSET CellType "CellType" is not defined
12545 complex(a(Aflibercept),p(HGNC:VEGFA)) -- path(DO:"pancreatic cancer") [pos:10] "Aflibercept" should be qualified with a valid namespace
12561 SET Gender = "Male" "Gender" is not defined
12563 UNSET Gender "Gender" is not defined
12590 SET CancerCause = "ROS1-rearrangment" "CancerCause" is not defined
12592 UNSET CancerCause "CancerCause" is not defined
12640 g(HGNC:ALK, fus(HGNC:WDCP)) -- path(MESHD:"Colorectal Neoplasms") "WDCP" is not in the HGNC namespace
12666 p(TruMBD4) -> a("5-fluorouracil sensitivity") [pos:2] "TruMBD4" should be qualified with a valid namespace
12675 SET CancerCause = "microsatellite instability" "CancerCause" is not defined
12677 UNSET CancerCause "CancerCause" is not defined
12686 SET CancerCause = "microsatellite instability" "CancerCause" is not defined
12687 SET CarcinomaType = "Sporadic" "CarcinomaType" is not defined
12689 UNSET CancerCause "CancerCause" is not defined
12690 UNSET CarcinomaType "CarcinomaType" is not defined
12700 SET Race = "Hispanics" "Hispanics" is not defined in the Race annotation
12703 UNSET Race "Race" is not set, so it can't be unset
12741 SET CancerCause = "serrated adenomas/polyps" "CancerCause" is not defined
12744 UNSET CancerCause "CancerCause" is not defined
12819 SET CancerCause = "inflammatory bowel disease" "CancerCause" is not defined
12822 UNSET CancerCause "CancerCause" is not defined
12828 SET CancerCause = "inflammatory bowel disease" "CancerCause" is not defined
12830 UNSET CancerCause "CancerCause" is not defined
12868 SET CarcinomaType = "highly methylated CRC" "CarcinomaType" is not defined
12874 UNSET CarcinomaType "CarcinomaType" is not defined
12882 SET CancerCause = "microsatellite instability" "CancerCause" is not defined
12884 UNSET CancerCause "CancerCause" is not defined
12891 SET AdenomaType = "Sessile serrated" "AdenomaType" is not defined
12892 SET PolypsType = "Microvesicular hyperplastic" "PolypsType" is not defined
12895 UNSET PolypsType "PolypsType" is not defined
12896 UNSET AdenomaType "AdenomaType" is not defined
12955 SET Gender = "Female" "Gender" is not defined
12957 UNSET Gender "Gender" is not defined
12972 SET TumorLocation = "Right-sided" "TumorLocation" is not defined
12974 UNSET TumorLocation "TumorLocation" is not defined
13010 SET Gender = "Male" "Gender" is not defined
13012 UNSET Gender "Gender" is not defined
13106 SET CellType = "Circulating tumor cells" "CellType" is not defined
13107 g(HGNC:KRT20) negativeCorrelation a("Survival Rate") [pos:36] "Survival Rate" should be qualified with a valid namespace
13108 g(HGNC:BIRC5) negativeCorrelation a("Survival Rate") [pos:36] "Survival Rate" should be qualified with a valid namespace
13109 UNSET CellType "CellType" is not defined
13115 SET CarcinomaType = "Metastatic" "CarcinomaType" is not defined
13116 SET CellType = "Circulating tumor cells" "CellType" is not defined
13117 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13118 g(HGNC:KRT20) biomarkerFor a("Survival Rate") General Parser Failure on line 13118 at pos 27: g(HGNC:KRT20) biomarkerFor a("Survival Rate")
13119 g(HGNC:BIRC5) biomarkerFor a("Survival Rate") General Parser Failure on line 13119 at pos 27: g(HGNC:BIRC5) biomarkerFor a("Survival Rate")
13120 UNSET CellType "CellType" is not defined
13121 UNSET CarcinomaType "CarcinomaType" is not defined
13122 UNSET Disease "Disease" is not set, so it can't be unset
13133 p("HepPar-1") biomarkerFor path(MESHD:"Carcinoma, Hepatocellular") [pos:2] "HepPar-1" should be qualified with a valid namespace
13144 a("low-dose gamma ray") -- g(HGNC:KRT20) [pos:2] "low-dose gamma ray" should be qualified with a valid namespace
13145 a("low-dose gamma ray") -- g(HGNC:ABCB1) [pos:2] "low-dose gamma ray" should be qualified with a valid namespace
13146 a("low-dose gamma ray") -- g(HGNC:CTNNB1) [pos:2] "low-dose gamma ray" should be qualified with a valid namespace
13147 a("low-dose gamma ray") -| path(MESHD:"Colorectal Neoplasms") [pos:2] "low-dose gamma ray" should be qualified with a valid namespace
13153 a(Platelets) -- a("circulating tumor cells") [pos:2] "Platelets" should be qualified with a valid namespace
13154 a("circulating tumor cells") -- path(DO:cancer) [pos:2] "circulating tumor cells" should be qualified with a valid namespace
13158 a(CHEBI:hydroxyethylcellulose) -| a(Platelets) [pos:36] "Platelets" should be qualified with a valid namespace
13162 g(HGNC:KRT20) positiveCorrelation a(Platelets) [pos:36] "Platelets" should be qualified with a valid namespace
13183 SET AdenomaType = "Sessile serrated" "AdenomaType" is not defined
13188 UNSET AdenomaType "AdenomaType" is not defined
13195 SET CarcinomaType = "Sporadic" "CarcinomaType" is not defined
13198 UNSET CarcinomaType "CarcinomaType" is not defined
13208 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13209 g(HGNC:KRT20) biomarkerFor a("circulating tumor cells") General Parser Failure on line 13209 at pos 27: g(HGNC:KRT20) biomarkerFor a("circulating tumor cells")
13210 UNSET Disease "Disease" is not set, so it can't be unset
13218 path("Perianal Paget") isA path(DO:"squamous cell carcinoma") [pos:5] "Perianal Paget" should be qualified with a valid namespace
13225 g(HGNC:KRT7) -- path("Perianal Paget") [pos:21] "Perianal Paget" should be qualified with a valid namespace
13226 g(HGNC:KRT20) -- path("Perianal Paget") [pos:22] "Perianal Paget" should be qualified with a valid namespace
13227 g(HGNC:PIP) -- path("Perianal Paget") [pos:20] "Perianal Paget" should be qualified with a valid namespace
13233 SET perianalPagetType = "Primary" "perianalPagetType" is not defined
13234 g(HGNC:KRT7) -- path("Perianal Paget") [pos:21] "Perianal Paget" should be qualified with a valid namespace
13235 g(HGNC:PIP) -- path("Perianal Paget") [pos:20] "Perianal Paget" should be qualified with a valid namespace
13236 UNSET perianalPagetType "perianalPagetType" is not defined
13238 SET perianalPagetType = "Secondary" "perianalPagetType" is not defined
13239 g(HGNC:KRT7) -- path("Perianal Paget") [pos:21] "Perianal Paget" should be qualified with a valid namespace
13240 g(HGNC:KRT20) -- path("Perianal Paget") [pos:22] "Perianal Paget" should be qualified with a valid namespace
13241 g(HGNC:PIP) -- path("Perianal Paget") [pos:20] "Perianal Paget" should be qualified with a valid namespace
13242 UNSET perianalPagetType "perianalPagetType" is not defined
13248 SET perianalPagetType = "Secondary" "perianalPagetType" is not defined
13249 g(HGNC:CDX2) -- path("Perianal Paget") [pos:21] "Perianal Paget" should be qualified with a valid namespace
13250 UNSET perianalPagetType "perianalPagetType" is not defined
13253 SET perianalPagetType = "Primary" "perianalPagetType" is not defined
13254 g(HGNC:CDX2) -- path("Perianal Paget") [pos:21] "Perianal Paget" should be qualified with a valid namespace
13255 UNSET perianalPagetType "perianalPagetType" is not defined
13283 g(HGNC:CDX2) negativeCorrelation a("Survival Rate") [pos:35] "Survival Rate" should be qualified with a valid namespace
13318 a(CHEBI:Lonsurf) -| p(HGNC:TYMP) "Lonsurf" is not in the CHEBI namespace
13327 a(CHEBI:Lonsurf) -| path(MESHD:"Colorectal Neoplasms") "Lonsurf" is not in the CHEBI namespace
13328 a(CHEBI:Lonsurf) -> a(CHEBI:Lonsurf) "Lonsurf" is not in the CHEBI namespace
13351 a(CHEBI:curcumin) -| p(SCOMP:"Nfkb Complex") Protein SCOMP:Nfkb Complex should be encoded as one of: Complex
13356 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13357 SET CellLine = {"HCT 116","HT-29"} "HCT 116" is not defined in the CellLine annotation
13358 a(EF31) -| p(SCOMP:"Nfkb Complex") [pos:2] "EF31" should be qualified with a valid namespace
13359 a(UBS109) -| p(SCOMP:"Nfkb Complex") [pos:2] "UBS109" should be qualified with a valid namespace
13360 a(UBS109) -| bp(GOBP:"cell cycle") [pos:2] "UBS109" should be qualified with a valid namespace
13361 a(EF31) -| bp(GOBP:"cell cycle") [pos:2] "EF31" should be qualified with a valid namespace
13362 UNSET Disease "Disease" is not set, so it can't be unset
13363 UNSET CellLine "CellLine" is not set, so it can't be unset
13370 SET CellType = "Cancerous" "CellType" is not defined
13371 a(UBS109) -| bp(GOBP:"cell growth") [pos:2] "UBS109" should be qualified with a valid namespace
13372 a(EF31) -| bp(GOBP:"cell growth") [pos:2] "EF31" should be qualified with a valid namespace
13373 a(UBS109) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "UBS109" should be qualified with a valid namespace
13374 a(EF31) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "EF31" should be qualified with a valid namespace
13375 UNSET CellType "CellType" is not defined
13394 SET TumorLocation = "Right-sided" "TumorLocation" is not defined
13397 UNSET TumorLocation "TumorLocation" is not defined
13399 SET TumorLocation = "Left-sided" "TumorLocation" is not defined
13402 UNSET TumorLocation "TumorLocation" is not defined
13404 SET TumorLocation = "Rectosigmoid" "TumorLocation" is not defined
13409 UNSET TumorLocation "TumorLocation" is not defined
13414 SET TumorLocation = {"Right-sided","Rectum"} "TumorLocation" is not defined
13416 UNSET TumorLocation "TumorLocation" is not defined
13425 a(Fluoropyrimidine) -| path(MESHD:"Colorectal Neoplasms") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13428 a(Fluoropyrimidine) -| path(MESHD:"Ovarian Neoplasms") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13429 a(Fluoropyrimidine) -| path(MESHD:"Gastrointestinal Neoplasms") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13430 a(Fluoropyrimidine) -| path(MESHD:"Gastrointestinal Neoplasms") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13435 a(Fluoropyrimidine) -- path(MESHD:"Neurotoxicity Syndromes") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13437 a(CHEBI:oxaliplatin) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13438 a(Fluoropyrimidine) -- path(MESHD:"Drug Toxicity") [pos:2] "Fluoropyrimidine" should be qualified with a valid namespace
13447 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13449 UNSET Disease "Disease" is not set, so it can't be unset
13455 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13460 UNSET Disease "Disease" is not set, so it can't be unset
13481 SET CarcinomaType = "Pulmonary pleomorphic carcinoma" "CarcinomaType" is not defined
13483 UNSET CarcinomaType "CarcinomaType" is not defined
13491 SET CarcinomaType = "Pulmonary pleomorphic carcinoma" "CarcinomaType" is not defined
13493 UNSET CarcinomaType "CarcinomaType" is not defined
13511 p(HGNC:DUT) causesNoChange a("FTD-triphosphate") [pos:29] "FTD-triphosphate" should be qualified with a valid namespace
13513 p(HGNC:DUT) -| a("FdUrd-triphosphate") [pos:17] "FdUrd-triphosphate" should be qualified with a valid namespace
13523 g(HGNC:ABCB1) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13528 g(dbSNP:rs2072671) -- g(HGNC:CDA) "dbSNP" is not a defined namespace
13529 g(dbSNP:rs2072671) -- path(MESHD:"Drug Toxicity") "dbSNP" is not a defined namespace
13534 g(HGNC:TYMS) -- g(dbSNP:rs45445694) "dbSNP" is not a defined namespace
13535 g(dbSNP:rs45445694) -- path(MESHD:"Hand-Foot Syndrome") "dbSNP" is not a defined namespace
13539 g(HGNC:ENOSF1) -- g(dbSNP:rs2612091) "dbSNP" is not a defined namespace
13540 g(dbSNP:rs2612091) -- path(MESHD:"Hand-Foot Syndrome") "dbSNP" is not a defined namespace
13567 SET CellType = "5-FU-resistant" "CellType" is not defined
13568 g(HGNC:MIR203A) negativeCorrelation a(chemoresistance) [pos:38] "chemoresistance" should be qualified with a valid namespace
13569 UNSET CellType "CellType" is not defined
13575 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13577 UNSET Disease "Disease" is not set, so it can't be unset
13586 g(HGNC:TYMS) negativeCorrelation a("5-fluorouracil sensitivity") [pos:35] "5-fluorouracil sensitivity" should be qualified with a valid namespace
13614 SET Disease = {"Colorectal Neoplasms", "Adenocarcinoma, Papillary"} "Colorectal Neoplasms" is not defined in the Disease annotation
13616 UNSET Disease "Disease" is not set, so it can't be unset
13618 SET Disease = "Leukemia, Promyelocytic, Acute" "Leukemia, Promyelocytic, Acute" is not defined in the Disease annotation
13620 UNSET Disease "Disease" is not set, so it can't be unset
13638 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13639 g(HGNC:TYMS) -- a(recurrence) [pos:18] "recurrence" should be qualified with a valid namespace
13640 g(HGNC:SMAD4) -- a(recurrence) [pos:19] "recurrence" should be qualified with a valid namespace
13641 UNSET Disease "Disease" is not set, so it can't be unset
13655 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13656 g(dbSNP:rs11942466) -- g(HGNC:AREG) "dbSNP" is not a defined namespace
13657 g(dbSNP:rs11942466) -- a("pathological complete response") "dbSNP" is not a defined namespace
13658 UNSET Disease "Disease" is not set, so it can't be unset
13663 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13664 g(dbSNP:rs11615) -- g(HGNC:ERCC1) "dbSNP" is not a defined namespace
13665 g(dbSNP:rs11615) -- a("pathological complete response") "dbSNP" is not a defined namespace
13667 UNSET Disease "Disease" is not set, so it can't be unset
13678 g(HGNC:DPYD) -- g(dbSNP:rs12132152) "dbSNP" is not a defined namespace
13679 g(dbSNP:rs12132152) -- path(MESHD:"Drug Toxicity") "dbSNP" is not a defined namespace
13684 p(HGNC:DPYD, sub(A,551,T)) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13690 g(HGNC:ENOSF1) -- g(dbSNP:rs2612091) "dbSNP" is not a defined namespace
13691 g(dbSNP:rs2612091) -- path(MESHD:"Drug Toxicity") "dbSNP" is not a defined namespace
13710 g(HGNC:TYMS) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13711 g(HGNC:DPYD) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13712 g(HGNC:MTHFR) -- path(MESHD:"Drug Toxicity") "Drug Toxicity" is not in the MESHD namespace
13768 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
13769 g(HGNC:HGF) positiveCorrelation a("microsatellite instability") [pos:34] "microsatellite instability" should be qualified with a valid namespace
13770 UNSET Disease "Disease" is not set, so it can't be unset
13772 a("microsatellite instability") -- path(MESHD:"Colorectal Neoplasms") [pos:2] "microsatellite instability" should be qualified with a valid namespace
13781 SET Race = "Hispanics" "Hispanics" is not defined in the Race annotation
13784 UNSET Race "Race" is not set, so it can't be unset
13790 a("microsatellite instability") positiveCorrelation path(DO:"colorectal adenocarcinoma") [pos:2] "microsatellite instability" should be qualified with a valid namespace
13846 g(HGNC:MLH1) -- path("Constitutional mismatch repair deficiency syndrome") [pos:21] "Constitutional mismatch repair deficiency syndrome" should be qualified with a valid namespace
13847 g(HGNC:MSH2) -- path("Constitutional mismatch repair deficiency syndrome") [pos:21] "Constitutional mismatch repair deficiency syndrome" should be qualified with a valid namespace
13848 g(HGNC:MSH6) -- path("Constitutional mismatch repair deficiency syndrome") [pos:21] "Constitutional mismatch repair deficiency syndrome" should be qualified with a valid namespace
13849 g(HGNC:PMS2) -- path("Constitutional mismatch repair deficiency syndrome") [pos:21] "Constitutional mismatch repair deficiency syndrome" should be qualified with a valid namespace
13924 SET Gender = "Female" "Gender" is not defined
13925 SET Disease = "Lynch Syndrome II" "Lynch Syndrome II" is not defined in the Disease annotation
13932 UNSET Gender "Gender" is not defined
13933 UNSET Disease "Disease" is not set, so it can't be unset
13994 SET CarcinomaType = "Sporadic" "CarcinomaType" is not defined
13999 UNSET CarcinomaType "CarcinomaType" is not defined
14016 SET FluidAndSecretion = "Mucus" "FluidAndSecretion" is not defined
14017 SET Disease = "Colorectal Neoplasms" "Colorectal Neoplasms" is not defined in the Disease annotation
14021 UNSET FluidAndSecretion "FluidAndSecretion" is not defined
14022 UNSET Disease "Disease" is not set, so it can't be unset

Top Warnings

Error Frequency
"CarcinomaType" is not defined 75
"Disease" is not set, so it can't be unset 57
"dbSNP" is not a defined namespace 45
"GenoType" is not defined 37
"Colorectal Neoplasms" is not defined in the Disease annotation 35
"CellType" is not defined 32
"DigestiveSystem" is not defined 30
[pos:2] "Cetuximab" should be qualified with a valid namespace 27
"CancerCause" is not defined 22
[pos:2] "cancer stem cells" should be qualified with a valid namespace 20
"irinotecan" is not in the CHEBI namespace 15
"metastatic" is not defined in the DiseaseType annotation 13
"Pathway" is not defined 13
[pos:2] "NT157" should be qualified with a valid namespace 12
"AdenomaType" is not defined 12
"Neoplasms" is not defined in the Disease annotation 12
"H1299 cell line" is not defined in the CellLine annotation 11
"Wnt receptor signaling pathway" is not in the GOBP namespace 10
"Gender" is not defined 10
"TumorLocation" is not defined 10

Naked Names 202

Names referenced without a namespace are antithetical to reproducible science and data integration practices. The list of "naked names" can be downloaded here for further use with tools to help find the appropriate names.

Undefined Namespaces 4

The source BEL script contained references to the following namespaces, but they were never defined. Click the links to download them as enumerated namespaces, and update the BEL script accordingly.

Namespaces with Incorrect Names 6

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of the open source project, PyBEL. Please feel free to contact us here to give us feedback or report any issues.